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ABSTRACT
The resistance and immunologic responses of a Beg
susceptible (C57BL/6) and Beg resistant (C3H/He) strain of
mouse were compared after infection with Mycobacterium
paratuberculosis.

Bacterial resistance was evaluated by

bacterial counts and histopathology of chronically infected
mice.

Levels of non-specific macrophage activation and the

response of various T cell subsets were also evaluated
following infection.
Susceptible mice orally infected with Mycobacterium
paratuberculosis developed granulomatous lesions containing
acid-fast bacteria in the mesenteric lymph nodes.
Significant differences in CFU of M. paratuberculosis
were observed between C57BL/6 and C3H/He mice following an
i.p. infection.

Susceptible mice failed to limit bacterial

proliferation, while bacterial counts progressively
declined in resistant mice.

Susceptible mice had numerous

granulomas in the liver and developed mesenteric lymph node
lesions.

Resistant mice had fewer hepatic granulomas and

did not develop mesenteric lymph nodes lesions.
Both strains of mice developed similar levels of non
specific macrophage activation

10

days after i.p. infection

with M. paratuberculosis as determined by a listeria
challenge assay.
Differences were detected in the proportions of T
cell subsets and activation markers between the two

ix

strains.

Both control and infected C3H/He mice had higher

percentages of CD4+ cells, whereas C57BL/6 mice had higher
proportions of CD 8 + and

7

S cells.

Both strains responded

to the initial infection with increased numbers of CD 8 +
and/or

7

S cells, but resistant mice responded with higher

proportions of CD4+ cells, whereas C57BL/6 mice responded
with higher percentages of

7

S T and/or CD 8 + cells.

Differences in the expression of CD25+ and CD44+
cells were also detected between the two strains of mice.
Expression of CD25 increased in resistant mice, but
decreased in susceptible mice after infection.

Overall

CD44 expression was higher in susceptible mice but
increased after infection in both mice.
These data suggest that resistance to M.
paratuberculosis is associated with higher proportions of
CD4+ T cells, while CD 8 + and/or
with susceptibility.

7

$ T cells are associated

The decrease in CD25 receptor

expression in susceptible mice suggests that a
dysregulation in IL-2 or its receptor may also be involved
in the pathogenesis of paratuberculosis.

x

CHAPTER 1.

INTRODUCTION, LITERATURE REVIEW, AND OBJECTIVES
The Disease in Ruminants

Introduction
Paratuberculosis (Johne's disease) is a chronic,
granulomatous, intestinal disease of domestic and wild
ruminants caused by the acid-fast bacterium Mvcobacterium
paratuberculosis (1.1,1.2).

The disease is characterized

by progressive emaciation in all species affected, and in
cattle by chronic, intermittent diarrhea (1.3).

The

infection is usually limited to the intestinal tract and
mesenteric lymph nodes.

Rarely, infections may disseminate

via the bloodstream resulting in lesions in the liver,
spleen, lung, kidneys, udders, genital organs, uterus, and
fetal tissues (1.4-10).

This disease has a worldwide

distribution and causes major economic losses in the
cattle, sheep, and goat industries (1 .1 ,1 .2 ).
Historical Overview
Paratuberculosis has probably been responsible for
considerable cattle losses in parts of Europe for over 200
years (1.2).

The earliest mention of possible cases of

paratuberculosis may be from d'Aroval, who in 1826 reported
a form of enteritis which occurred in some cattle with
chronic diarrhea (1.2).

The characteristic thickening and

corrugation of the intestinal mucosa in cattle dying from
this disease was first described in 1881 by Hansen and
Nielsen (1.2).

The disease was further described in 1895
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by Johne and Frothingham who first demonstrated the
presence of acid-fast bacilli in the intestinal tissues of
diseased cattle (1.11).

The presence of these bacilli led

them to believe that the disease was an unusual form of
tuberculosis.

In 1906 the disease was reclassified by Bang

as being distinct from tuberculosis and he coined the
phrases "pseudo-tuberculosis enteritis" and "Johne's
disease" to describe the condition (1.12). The disease was
first reported in the United States in 1908 (1.13).

The

organism was first isolated and cultured in vitro in 1910
by Twort who named the organism Mycobacterium enteriditis
chronicae pseudotuberculosae bovis iohnei (1.14).

The name

was later unofficially shortened to Mycobacterium iohnei in
several publications.

Eventually the disease became known

as paratuberculosis or Johne's disease and the name of the
causative organism was officially changed to Mycobacterium
paratuberculosis (1.2,1.15).
Clinical Features
Although animals become infected at an early age,
signs of the disease usually do not occur until the animal
is two to five years of age.

Due to the slowly progressive

nature of the disease, infected cattle may not display
clinical signs of the disease for years after infection.
By the time the first case in a herd is diagnosed, 38-42%
of the herd may be infected (1.16).
may range from less than
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The incubation period

months to over 15 years (1.17)
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but the majority of cases occur between 3-5 years of age
(1.2).

The youngest reported case was in a 4-month-old

calf (1.18) and the oldest reported case occurred in a 15year-old cow (1.17).

The first clinical sign of a

chronically infected cow is a non-responsive, chronic,
intermittent diarrhea.

Temporary periods of remission,

lasting weeks to months, may occur. The diarrhea may
subside during pregnancy, but will often return with
greater severity following parturition (1 .2 ).
Clinical pathology values are either within normal
limits or non-specific.

The most common abnormalities are

hypoproteinemia and anemia (1.19). Hypoproteinemia occurs
due to a combination of protein loss and malabsorption
(1.19).

Anemia of chronic disease may occur (1.19).

Despite a normal appetite, infected animals eventually
have significant weight loss, unthriftiness, dry skin, and
a rough, shaggy hair coat (1.2).
usually occur within

6

Emaciation and death

months from the onset of clinical

signs but the course of the disease may persist for several
years.

The disease may progress more rapidly in sheep and

goats (1 .2 ).
Although the diagnosis of paratuberculosis in an
animal with the typical clinical signs of the disease may
be uncomplicated, the recognition of subclinical infections
and inapparent carriers is more difficult.

An infected

herd may lack clinically apparent cases, yet there may be
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significant decreases in weight gains, decreased milk
production and quality, high rates of infertility, and
increased susceptibility to mastitis and other concurrent
infections (1 .2 ,1 .2 0 ,1 .2 1 ).
Although controversial, there is a possibility that
certain breeds are predisposed to paratuberculosis.

Field

observations indicate a much higher prevalence in the
Channel Island and Shorthorn breeds of cattle, but this
might be related to increased exposure rather than to
increased susceptibility (1.3).
Pathology
Cattle chronically infected with paratuberculosis
develop marked thickening and non-stretchable rugal
corrugation of the mucosal surface of the affected portions
of the intestines.

The lesions are usually confined to the

ileum and upper small intestine but the disease may involve
the entire small intestinal tract and colon.

There is also

mesenteric lymphadenopathy, with the mesenteric lymph nodes
being the earliest organs in which the organisms and
lesions can be detected following experimental infection
(1.16,1.22).

Cording of the subserosal and mesenteric

lymphatics may be observed due to obstruction of the
lymphatic flow.
In approximately one third of clinical cases of
paratuberculosis, calcification of the endocardium and/or
aorta occurs (1.23).

The cause of this lesion is unknown

but may be related to an activation of circulating
macrophages which produce vitamin D3 as a side product
(1.23).
Histologically, the intestinal thickening and mucosal
corrugation is due to marked infiltration of the tissues
with epithelioid macrophages (1.2).

Although there is

variation between cases, the typical lesion has multifocal
to diffuse infiltration with macrophages and Langhans-type
multinucleated giant cells in both the intestines and
mesenteric lymph nodes (1.16).

Macrophages usually

infiltrate and distend the lamina propria and submucosa cf
the small intestine and colon.

These macrophages and giant

cells contain variable numbers of acid-fast bacilli (1.16).
Macrophages and giant cells may also be observed in the
stroma of the muscularis mucosa and the serosa (1.24).

In

affected regions, intestinal villi are shortened and
distorted (1.24).

Lymphatic vessels in the lamina propria

are often dilated and occasionally ruptured (1.24).
Microscopic lesions are usually limited to the intestine,
mesenteric and ileocecal lymph nodes, but occasionally
extra-intestinal lesions may occur.
The spectrum of lesions in ruminant paratuberculosis
has been compared to the spectrum of lesions observed in
human leprosy patients (1.16,1.25).

The tuberculoid end of

the leprosy spectrum is characterized by granulomas with
necrosis, fibrosis, numerous Langhans giant cells, and very

few detectable acid-fast bacilli, while the lepromatous
pole is characterized by numerous acid-fast bacilli and
abundant histiocytes and epithelioid macrophages, with
minimal necrosis or fibrosis (1.16,1.25).

This spectrum is

also seen in paratuberculosis and although not yet proven
for cattle, may correspond to the immunologic status of the
host (1.16).

The differences in the lesions suggest that

there are varying degrees of cell-mediated immunity
expressed in individual infected cattle.

It is not known

whether these variable degrees of immunity are the result
of alternating changes in the immune status of the infected
individual, or of genetic predispositions of certain cattle
to develop a stronger cell-mediated immune response.
Diagnosis
Immunologic Methods
Although numerous attempts have been made, there is
still a lack of a reliable test for detection of animals
infected with IL paratuberculosis.

Most tests for the

presence of infection have either poor sensitivity, poor
specificity, or both.

Previous diagnostic methods that

have been used or evaluated include the intradermal and
intravenous johnin tests (1.26-30), complement fixation
(1.31), hemagglutination (1.32), agar gel immunodiffusion
(1.33,1.34), enzyme-linked immunosorbent assay (1.35-37),
radioimmunoassay (1.38), indirect fluorescent antibody
(1.39), lymphocyte transformation (1.40-43), leukocyte

migration inhibition (1.44), lymphocyte stimulation (1.41),
immunoperoxidase (1.45), mucosal and lymph node biopsy
(1.46), and fecal culture (1.2,1.47,1.48).
Most of these methods rely on immunological reactions,
which is actually an indicator of exposure rather than of
current infection.
between

Furthermore, cross-reactivity occurs

paratuberculosis. and other species in the

Mycobacterium avium-intracellulare (MAI) group, which are
ubiquitous in the environment (1.49).

Tests for anti-

mycobacterial antibodies that employ crude antigen
preparations such as protoplasmic extractions or PPD may
also cross react with other organisms including
Actinomvcetes spp., Dermatophilus spp., Nocardia spp.,
Streptomvces spp., Corvnebacterium spp., and even fungi
(1.2,1.50,1.51).

Most immunologic assays are therefore

limited by false-positive reactions and cannot be
accurately relied upon for the diagnosis of individual
cattle or eradication programs.

To further complicate the

issue, a state of immunologic tolerance (anergy) frequently
occurs during the early phase of the infection, in which
the infected animal exhibits neither delayed
hypersensitivity or serologic responses (1.1).

In

addition, chronic infection with paratuberculosis may also
lead to a state of anergy, which means that even heavilyinfected animals may test negative when immunologic-based
assays are used (1 .2 ).

Currently there is a commercially available, pre
absorbed ELISA test that is apparently more specific for
Mycobacterium paratuberculosis than previous ELISA's
(1.52).

The Johne's Absorbed EIA (Commonwealth Serum

Laboratories, Parkville, Australia) has an improved
specificity because it utilizes a pre-absorption step to
remove antibodies reacting with Mvcobacterium phlei
antigens, thus reducing the likelihood of cross-reactivity
with other mycobacteria (1.52).

Although this test is more

reliable than previous diagnostic tests, there is still the
problem of anergy in chronically infected cows resulting in
false negatives, regardless of the type of immunologicbased test used.
Fecal Culture
The only practical and cost-effective means by which a
definitive antemortem diagnosis can be made at this time is
to culture the organism from tissues or feces.

Fecal

culture has been called the "gold standard" of
paratuberculosis testing due to its presumed
specificity (1.48,1.53).

100%

It is also used as the standard

by which other assays are most often compared.

If

performed correctly, fecal cultures are considered to be
the most sensitive and specific test to detect infected
cattle (1.48,1.53).

However, even this may be challenged

as it has been recently shown that uninfected adult cattle
may pass Mycobacterium

paratuberculosis in their feces
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when orally inoculated with the organism (1.54).

Although

this is probably a rare occurrence, this suggests that
normal, uninfected cattle grazing on infected pastures
might passively excrete the organism in feces, resulting in
false-positive culture results (1.54).
Although fecal culture is currently the most specific
and sensitive test for paratuberculosis (1.48), the long
incubation period of the organism (weeks to months) makes
this method an unsuitable diagnostic test for eradication
programs.

In addition, a minimum of 10-100 viable

Mycobacterium paratuberculosis organisms must be present
per gram of feces before culture techniques can detect
infected animals (1.55).
Polymerase Chain Reaction (PCR) Testing
More recent methods of diagnosing paratuberculosis
are focusing on the polymerase chain reaction (PCR) which
can detect smaller numbers of Mycobacterium
paratuberculosis in feces or tissues (1.56-58).

Once

perfected and commercially available, these methods will be
able to detect Mycobacterium paratuberculosis DNA in the
feces of infected animals in a matter of hours, resulting
in a diagnostic assay that provides almost immediate test
results and that may eventually exceed the sensitivity of
fecal culture.

Specific sequences of Mycobacterium

paratuberculosis DNA have already been cloned to use in
these assays.

The insertion sequence IS900 is unique to
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Mycobacterium paratuberculosis and is currently in use as a
target for a specific and sensitive DNA probe (1.58,1.59).
This sequence encodes for a single antigenic protein
referred to as p43, and methods are currently being
evaluated for using this protein as a diagnostic marker
(1.59).

Comparisons of fecal culture to DNA probe methods,

however, show that the sensitivity is currently similar in
both methods (1.55,1.58).
Microbiology
Mycobacterium paratuberculosis. the causative agent of
paratuberculosis, is a small (0.5/xm x 1.5/zm), acid-fast,
Gram-positive, non-motile, facultative, rod-shaped bacillus
(1.2).

The organism can remain viable in feces and soil

for over 11 months (1.2).

Although many previous attempts

had been made, culture of the organism was first achieved
by enriching the medium with killed tuberculosis bacilli
(1.14,1.60).

It is now generally accepted that all bona

fide strains of Mycobacterium paratuberculosis are
mycobactin dependent (1.61).

The reverse is not

necessarily true, as certain strains of the M.
avium/intracellulare (MAI) complex are also mycobactin
dependent (1.61).

Fortunately, MAI bacilli are

comparatively rapid growers compared to M.
paratuberculosis. making the distinction between these
closely related organisms possible without the use of
sophisticated techniques (1.61).

The role of iron in the pathogenesis of
paratuberculosis has been examined (1.61-66), but the
mechanisms involved are as yet unclear.

Like other

mycobacteria, M. paratuberculosis has a high requirement
for iron to sustain growth, and has developed mechanisms to
obtain and transport iron across its cell membranes
(1.16,1.62).

Mycobacteria produce at least two kinds of

iron binding compounds, mycobactin and exochelin, both of
which are siderophores utilized to obtain iron from the
environment (1.63).

It has been proposed that lymphatic

damage and subsequent leakage of lymph into the intestinal
tissues may provide the higher iron concentration in the
intestinal tissues required for proliferation of the
organisms (1.64).

Granulomatous lesions of

paratuberculosis have been shown to contain ferritin,
lactoferrin, and transferrin (1.63). Studies in mice have
demonstrated that the severity of the lesions does appear
to correlate with higher intracellular iron content (1.65).
On the other hand, supplementation of mice with mycobactin
J and/or lactoferrin seems to have no effect on the
multiplication of Mycobacterium paratuberculosis in
gnotobiotic mice (1.66). Furthermore, mycobactin cannot be
detected in tissues infected with Mycobacterium
paratuberculosis suggesting that once inside the host,
these organisms may utilize different mechanisms to acquire
iron (1.67).
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Epidemiology
Paratuberculosis is worldwide in distribution and the
prevalence appears to be increasing in some countries
(1.3).

In England, it is considered to be the most

economically important infectious disease of cattle (1 .1 ).
In the United States, the disease is present wherever there
are large concentrations of cattle (1.2,1.68-69).
Reliable estimates of the actual prevalence of the
disease are difficult to obtain due to the insidious nature
of the disease, the non-specificity of its clinical signs,
and the lack of reliable diagnostic testing procedures.
Only in the terminal stages of the disease do animals
display typical signs of diarrhea and weight loss.

Most of

the losses due to paratuberculosis are from decreased
productivity and secondary infections that do not prompt
clinicians or farmers to test for paratuberculosis.

Losses

due to subclinical disease such as decreased production,
infertility, mastitis and other secondary infections are
probably the most significant causes of economic losses in
an infected herd (1.2,1.5,1.21,1.70).
Most estimates of the prevalence were determined by
the isolation of M^. paratuberculosis from tissue specimens
(usually ileocecal lymph nodes) obtained from cattle at
slaughter (1.71).

One extensive survey found that the

overall prevalence of paratuberculosis in the United States
was 2.9% of the dairy cattle and 0.8% of the beef cattle
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(1.6% overall)

(1.72).

This is probably an underestimation

of the true prevalence, since the methods used in the study
utilized strong decontamination media (benzalkonium
chloride and/or hexadecylpyridinium chloride) which may
have killed many mycobacteria in the specimens, resulting
in false negatives.

Other studies indicate that at least

in certain parts of the United States, the prevalence of
paratuberculosis is much higher.
that

11%

(1.73).

A Wisconsin study found

of the cattle were infected with paratuberculosis
Another study that combined culture results with

histologic examination indicated that over 18% of the
cattle in the New England states are infected (1.74).
Most of these surveys report a higher incidence of
paratuberculosis in dairy cattle than in beef cattle
(1.71).

This might be attributed to the methods of

husbandry, since dairy cows are usually kept in closer
confinement, resulting in higher levels of fecal
contamination and exposure (1.75).

In addition, slaughter

house studies are based entirely upon cows sent to
slaughter, and the selection process for sending cows to
slaughter varies between dairy and beef cattle (1.75).
Dairy cattle that are sent to slaughter are usually
debilitated or have decreased milk production (1.75) and
therefore cows with paratuberculosis would be over
represented in this group.

In areas where beef cattle

populations greatly exceed dairy cattle populations,
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paratuberculosis is more prevalent in the former (1.75).
At this time, with the limited studies that have been
performed, a breed predilection in susceptibility to the
disease has not been proven (1 .2 ) but there may, however,
prove to be a genetically-linked susceptibility in cows
analogous to the Beg gene-associated susceptibility to
mycobacterial diseases in mice.
Economic Significance
Estimates of the financial losses to the beef and
dairy industries due to paratuberculosis vary.

The

economic losses in New England alone have been estimated at
over $15.4 million per year (1.74).

Economic losses in

Pennsylvania and New York have been estimated at $5.8 and
$6.4 million annually, respectively (1.71).

The Central

Animal Health Laboratory has estimated losses to the
Wisconsin dairy industry to exceed over $52 million per
year (1.71).

This means that based upon these surveys, a

farmer with an infected herd can expect annual losses of
$75 to $100 per adult cow (1.2).

Calculations of expected

versus actual production in paratuberculosis infected dairy
herds reveal that there is an

8%

reduction of total milk

production and a 30% decrease in slaughter value of culled
cows (1.71).

Since the current value of an average adult

dairy cow is only $1200 (1.71), continuous losses due to
paratuberculosis may be devastating to the average farmer.
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Transmission
Infection with Mycobacterium paratuberculosis is
initially acquired by oral ingestion of the bacilli by
young calves* usually less than three months of age (1 .2 ).
Inoculation of adult cows fails to cause successful
infection or results in mild or inapparent infections
(1.2).

The reason for the selective susceptibility of

young calves to infection is not known.
It is widely accepted that infection occurs when
calves nurse on teats contaminated with feces (1 .1 ,1 .2 ).
However, bacilli may also be ingested from contaminated
pastures or fomites (1.2).

In addition, recent studies

have shown that both clinically and subclinically infected
cows actually shed the organisms in their milk (1.76).
Mycobacterium paratuberculosis has also been cultured from
the fetuses of both infected cows showing clinical signs of
paratuberculosis (1.7,1.77-80) and cows not manifesting
clinical signs of the disease (1.81).

Although no cases of

vertical transmission resulting in clinical disease have
been proven, shedding of bacilli in the milk and/or in

utero infection might be important methods of transmitting
the disease.
Pathogenesis
Once ingested , M. paratuberculosis enters the gutassociated lymphoid tissues (GALT) through infection of the
tonsils or the Peyer's patches (1.22). The organism

selectively enters these sites by invading and traversing
the specialized intestinal epithelial cells called M cells
that completely cover the domes of lymphoid follicles in
the ruminant GALT tissues (1.82,1.83).

The reason bacilli

are selectively taken up by these cells is currently
unknown, but only live bacteria are taken up by M cells,
suggesting that the process is actively initiated by the
bacilli (1.83).

It has recently been shown that M.

paratuberculosis binds to fibronectin, an adhesive
glycoprotein expressed on host cell surfaces (1.84).

This

binding was shown to be specific for fibronectin, and not
present in other mycobacterial species tested (M^. phlei)
(1.84) .

This suggests that entry of M_j_ paratuberculosis

into host cells may be a specific, host-adapted, receptormediated event.
Once across the epithelium, M. paratuberculosis is
phagocytized by macrophages, in which it survives and
replicates intracellularly, being protected from humoral
and cell-mediated immune systems (1.1).

The organisms may

localize in the submucosa of the ileocecal tissue, or they
may be transported to the mesenteric lymph nodes
(1.2,1.16,1.22).

One hypothesis states that bacterial

replication occurs initially within the mesenteric lymph
nodes, and the intestines may not be involved until late in
the course of the disease (1.22).

This hypothesis is based

upon the observation that in experimentally infected
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cattle, granulomatous lesions and detectable acid-fast
bacilli are first found in the mesenteric lymph nodes
rather than the intestines (1.22).

Little is actually

known of the pathogenesis of the disease beyond the entry
stage, but lesions and bacterial proliferation are almost
always limited to the intestines and associated lymph nodes
(1 .2 ), suggesting a bacterial predilection for these sites.
This may be related to the organism's unusually high
requirement for exogenous sources of iron (1.16,1.62) which
it might acquire directly from the hosts gastrointestinal
tract.
Once the infection has commenced, bacterial
replication seems to progress unimpaired.

Although none of

the classical, known cell toxins are produced by the
bacteria, the ability to survive and replicate within
macrophages seems to be the organism's most damaging
virulence factor (1.1).

Factors have been isolated from M.

paratuberculosis that seem to have deleterious effects on
the macrophage's ability to kill Candida albicans (1.85).
Although these factors have not yet been completely
identified, they seem to be similar to factors of other
mycobacteria such as the lipoarabinomannan of M. leprae and
M. tuberculosis which has been shown to inhibit the
activation of macrophages (1.86).

These factors may play a

role in impairing the macrophage's ability to destroy the
mycobacteria as well (1 .8 6 ).
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Following infection, recruitment of macrophages into
the lesions occurs, probably due to the effects of soluble
factors (cytokines) released from infected cells (1 .2 ).
This granulomatous inflammation results in distortion of
the tissue architecture and impairment of function (1 .2 ).
Blood and lymphatic vasculature drainage is compromised
(1 .2 ) and plasma leakage from the gastrointestinal tract
occurs, resulting in decreased serum protein and an
increase in protein catabolism (1.87).

These factors,

along with a general intestinal malabsorption due to the
granulomatous tissue infiltration result in the severe
weight loss and cachexia typical of the terminal stages of
the disease (1 .2 ).
Treatment
To date, there are no cost-effective or practical
treatments for paratuberculosis.

Although the bacillus is

susceptible to many bacterial agents in vitro,
chemotherapeutic trials in vivo have not been successful
(1.2).

In most cases, treated animals transiently improve

clinically but continue to shed the bacillus and eventually
succumb to the disease (1.2).

The most effective drug

studied thus far in vivo has been clofazamine (1.1).

This

drug reduces the clinical signs of illness and decreases
fecal shedding of the bacilli by infected ruminants, but
relapse occurs if the drug is withdrawn, even after
days of treatment (1.1).

200

Therapeutic trials on mice have
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shown that rifabutin may decrease M. paratuberculosis
counts, but clearance of the bacteria does not occur, even
after

6

months of therapy (1 .8 8 ).

Although treatment of paratuberculosis is not yet a
viable alternative, the development of new
antimycobacterial agents and strategies might provide help
in combating this disease in the future.

Combination

therapy, often used against M. tuberculosis, has not yet
been evaluated against M. paratuberculosis in vivo.

Recent

reports have shown that combination therapy of
clarithromycin and ethambutol is significantly more
effective against M. paratuberculosis in vitro than either
of the two antibiotics when used alone.
Prevention
Prevention of paratuberculosis is difficult in that it
is currently centered on time-consuming husbandry and
management practices (1.1,1.2).

Calves are removed from

the dams immediately after birth and bottle-fed milk
replacers and colostrum from paratuberculosis-free cows
(1.1,1.2).

Fecal cultures or immunologic tests are

routinely performed on adults and positive reactors are
removed from the herd (1.2).

Cleaning and disposal of

fecal material is also an important step in reducing
bacterial contamination and spread (1 .1 ,1 .2 ).
There are a number of both attenuated and killed
vaccines available for paratuberculosis, but the efficacy

20
and ethics of their use is controversial (1.2).

The use of

either type of vaccine appears to result in a reduction of
the number of animals demonstrating clinical signs, yet
these animals continue to shed viable bacilli, thus
contributing to environmental contamination (1 .2 ).
Husbandry and control measures are required to obtain
maximum benefits (1.2).

More importantly, vaccination does

not confer absolute immunity to the disease (1 .2 ).
Numerous reports suggest that the type of soil may
determine whether Johne's disease will be a serious problem
(1.16,1.89,1.90).

Clinical cases of Johne's disease do not

seem to occur in cattle raised on soils with high pH or a
high lime (calcium carbonate) content (1.89,1.90).
Although some lesions and acid-fast bacteria occur
regardless of soil type, the clinical features of Johne's
disease; diarrhea and weight loss, do not seem to be a
problem in cows raised on alkaline soils (1.16).
Alkalinization of the soil in endemic areas by the
addition of crushed limestone has been incorporated into
the Environmental Paratuberculosis Inhibition Concept
(EPIC) guidelines as an integral part of the procedures
recommended to control paratuberculosis in endemic areas
(1.89) .
Laboratory Animal Models for Paratuberculosis
The apparent lack of a suitable laboratory animal
model for paratuberculosis has hampered research into the
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immunology, pathogenesis and therapeutics of the disease.
The literature describing the susceptibility of laboratory
animals to paratuberculosis is confusing and often
conflicting (1.91,1.92).

Failure to successfully infect

cats, guinea pigs, mice, rabbits, rats, hens, pigeons,
gerbils, and hamsters with

paratuberculosis (or M.

johnei) has been reported (1.14,1.92-101,1.26).

Some of

these researchers were successful with one species but
failed with another, while other researchers using the same
species would achieve opposite results.
Rabbits were the first laboratory animals that were
shown to develop classical lesions of Johne's disease
following an experimental inoculation of M.
paratuberculosis (1.14,1.92.1.96) Thickening and folding of
the intestinal mucosa and enlarged intestinal villi packed
with epithelioid macrophages filled with acid-fast bacilli
were observed in 25-45% of rabbits after 3-18 months of
infection (1.92,1.96). However, early studies with rabbits
were inconsistent, possibly due to variations in the strain
of rabbit and/or bacilli used, and the route of
inoculation.

Successful infections producing typical

lesions usually occurred in less than 50% of the animals
inoculated in the original studies
(1.14,1.92,1.96,1.102,1.103).

More recently, orally

infected rabbits have been demonstrated to be a suitable
model for producing lesions resembling those of Johne's
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disease in ruminants (1.104).

Infections were successfully

produced in 13 of 21 (62%) rabbits orally inoculated with
M. paratubercu1osis strain 19698 (1.104).

Evidence

suggests that, if the right strain and a large dosage of
organism is used, rabbits are a suitable model for studying
the pathogenesis of paratuberculosis.
Unfortunately, few immunologic reagents are currently
available for rabbits, which limits detailed investigations
into the immunology of the disease in this model.

A murine

model of the disease would be less expensive and would
provide a wider range of research applications.
Many studies have attempted to infect mice with M.
paratuberculosis but the results have varied between
experimenters (1.91,1.92,1.105).

Part of the paradox in

the literature regarding the susceptibility of mice may be
explained by the use of different strains of M.
paratuberculosis. differences in strains of mice used
(strains were not even mentioned in some studies (1.105),
varied routes of inoculation and dosage, and the wide
variety of substances used as the vehicle to deliver the
organisms.

Although it is now known that there are several

different strains of It paratuberculosis. most of the
earlier studies utilized wild-type strains isolated from
clinical cases of Johne's disease.
that different strains of

It is currently known

paratuberculosis can behave

differently in the same laboratory animal (1.91) and
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therefore the use of unclassified strains may produce
varied results in different species.
Intraperitoneal and intravenous infections have
resulted in the reproduction of paratuberculosis lesions in
mice in several studies (1.91,1.92,1.105-107).

The

development of intestinal lesions in susceptible strains of
mice using these routes of inoculation suggest that M.
paratuberculosis has a predilection for intestinal tissues.
Successful infections using oral routes of administration
have been achieved in SCID (1.107) and nude (1.108,1.109)
mice but the immunocompromised states of these animals may
preclude their use for certain investigative studies of the
immune response to infection.
Earlier studies using conventional, immunocompetent
mice have failed to demonstrate successful rates of
infections using the oral route of inoculation
(1.94,1.105,1.106,1.110).
and/or

However, the strain of mice

paratuberculosis used in some of these

experiments are unclear, and the genotype of the mice used
in all of the earlier studies was unknown (1.94,1.105).
The inability to infect mice with Mj. paratuberculosis in
earlier studies may have been due to the failure to use
genetically-defined strains of susceptible mice.

It is now

known that different strains of mice vary in their
resistance to mycobacterial diseases, depending upon their
genotype (1 .1 1 1 ).
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Genetic Regulation of Mycobacterial infections
The theory that genetic factors are important in the
susceptibility to mycobacterial infections has been
proposed for years (1.111).

However, most of the evidence

that supports the role of a genetic basis for
susceptibility to tuberculosis and related mycobacterial
infections in humans has been circumstantial (1 .1 1 1 ).
Differences in racial susceptibility (1.112), similarities
in the susceptibilities of twins (1.113), and associations
with specific chromosomal markers (1.114), have been
described for tuberculosis patients.

It should be noted

however, that resistance to mycobacterial infections is
multifactorial, and whether or not an individual is
susceptible to infection probably depends upon many other
factors as well, such as the general immune status of the
host, and the dose and route of exposure of the organism.
Although actual proof for a genetic basis for
susceptibility to mycobacterial infections in humans is
currently lacking, the association of certain genotypes
with susceptibility to tuberculosis has been known to exist
in rabbits since the 1930's (1.111).

Rabbits were

selectively inbred for their susceptibility to
tuberculosis, and it was shown that tuberculosis resistance
is dominant, multiple, and additive over that of
susceptibility (1.111.1.115).

Strain variation in the susceptibility of mice to
mycobacterial infections has been known since the 1940's
(1.111).

Survival times of various mouse strains infected

with Mi. tuberculosis vary considerably (1.116-1.118).
Patterns of resistance to tuberculosis in the progenitors
of C57BL/6J (susceptible) and Swiss (resistant) mice
suggested that the resistance was controlled by a single
dominant gene (1.119).

More extensive studies utilizing M.

bpvis/bacille Calmette-Geurin (BCG) infections demonstrated
that different strains of inbred mice could be distinctly
separated into either resistant or susceptible categories:
resistant strains with no or marginal bacterial growth, and
susceptible strains that allowed uncontrolled bacterial
proliferation of the bacteria (1.120).

Further

investigation of this differential susceptibility led to
the discovery of a single autosomal gene (Beg) located on
chromosome

1

of the mouse, which is expressed in two

allelic forms referred to as the dominant, resistance
allele {Beg') and the recessive, susceptibility allele
(Beg5) (1.121).

This gene also controls innate resistance

to M. lepraemurium. M. intracellulare. M. smegmatis. and M.
avium and is apparently identical to the Lsh and Jty loci
which control innate resistance to infection with
Leishmania donovani and Salmonella typhimurium.
respectively (1 .1 2 2 ).
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Inbred mice strains of the Beg* genotype include
BALB/c, DBA/1, C57BL/6, C57BL/10, and CE/J, while the
resistant genotype includes strains A/J, AKR, C3H/He,
C57BR/J, C57L/J, CBA, DBA/2, and 129/J (1.123).
The comparative susceptibility of C57, CBA, and Swiss
mice to an intraperitoneal infection with Mycobacterium
paratuberculosis has previously been studied (1 .1 1 0 ).
These experiments showed that C57 were indeed more
susceptible to infection, with Swiss mice being less so,
and CBA being relatively resistant (1.110).

Later

experiments, however, failed to demonstrate successful
infection of C57 mice using an oral route of inoculation
(1.106). However, this study predated the discovery of the

Beg gene and the Beg genotype of the C57 mice strain used
in those experiments was not known.

It is now known for

example, that the inbred strains C57BL/6 and C57BL/10 are
susceptible, yet C57BR and C57L are resistant (1.123). In
addition, the duration of the infection in question was
terminated at 9 months, and more importantly, the
mesenteric lymph nodes (which proved to be of particular
importance in the present studies - see chapter

2)

were not

examined (1.106).
The susceptibility of C3H/HeJ, C57BL/6J, and a number
of recombinant inbred strains of mice to an intravenous
infection with M. paratuberculosis has also been compared
using the number of hepatic granulomas as an index (1.124).
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A correlation was shown between Beg genotype and
susceptibility in response to the infection as determined
by histologic counts of hepatic granulomas developing after
50 days of infection.

Although actual bacterial numbers

were not determined, this study demonstrated that
resistance to M. paratuberculosis. like other mycobacterial
diseases, is associated with the Beg gene (1.124).
Although specific strains of mice may be sharply
divided into susceptible and resistant categories, there
are some discrepancies in the theory that mycobacterial
resistance is under the absolute control of a single gene.
Differences in the susceptibilities of BALB/c, C57BL/6 and
C57BL/10 mice to an intraperitoneal infection with M.
paratuberculosis have recently been reported (1.91).
Although these strains all have the Beg susceptible
genotype, BALB/c mice were shown to be relatively more
susceptible to infection than C57BL/10 mice, while C57BL/6
mice were of intermediate susceptibility (1.91).

This

suggests that even among inbred mice, resistance to
mycobacterial infections is probably multifactoral and
deserves further investigation.
The mechanism(s) by which the Beg alleles confer
resistance or susceptibility are not known.

Macrophages

from BcgT mice are superior to Beg* macrophages in H 202 and
0 2'

production, and hexose monophosphate shunt activity when

challenged with BCG (1.121).

However, macrophage killing
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of mycobacteria does not seem to be dependent upon
oxidative killing mechanisms (1.121,1.125).

Furthermore,

although antimycobacterial activity is inherently stronger
in Begr macrophages, Beg* macrophages can be stimulated by
cytokines to a level of anti-mycobacterial activity that
equals that of the Beg* macrophages (1.125).

Both

genetically resistant and cytokine-stimulated susceptible
macrophages have been demonstrated to have equal abilities
in killing of M. smecrmatis in vitro (1.125).

Macrophage

populations isolated from normal, uninfected, Bcgr mice
always contained more Ia+ (MHC 11+) cells than their Beg*
counterparts (1.121).

Furthermore, the frequency of Ia+

macrophages increases in response to an infection with M.
bovis/BCG in Beg' but not in Beg* mice (1.121).

Antigen

presentation to T cells is also enhanced in Begr
macrophages as compared to Beg* macrophages (1.121).

In

addition, more antigen-specific T cell proliferation and
increased IL-2 production has been observed in Beg* mice
compared to Bcgr3 mice (1.121).

This suggests that the Beg

gene may exert its effects at the level of macrophage
activation rather than on an inherent macrophage killing
function.

This defect (in susceptible animals) may either

be in the macrophage, T cell, or cytokine production
capabilities of either cell.
Although the equivalent of the Beg gene of mice has
not yet been described in humans or cattle, conservation of

genes between humans, cattle, and mice is well documented
(1.124.1.126). Currently the product of the Beg gene is not
known, but it is closely linked in the mouse chromosome to
the genes for isocitrate dehydrogenase, gamma crystalline,
and fibronectin (1.124,1.126,1.127).
located on the human chromosome
(1.126.1.127).

2q

These genes are

and bovine chromosome

8

Since gene homology is often conserved in

segments, there may be an equivalent gene in both humans
and cattle that encodes for mycobacterial susceptibility.
Studies are currently attempting to identify a human
homologue of the Beg gene (1.121).

If this gene is present

and identifiable in cattle, perhaps paratuberculosis and
several other important diseases of ruminants, such as
Salmonellosis, could be eliminated by selectively breeding
for resistant animals.
Immunology of Paratuberculosis
Very little is currently known about the immunology of
paratuberculosis as compared to other mycobacterial
diseases such as tuberculosis, leprosy, or It avium
infections.

The few immunologic studies that have been

performed in paratuberculosis have focused primarily on the
quest to develop immunologic diagnostic tests for the
disease.
Immunity to paratuberculosis, like other mycobacterial
diseases, is dependent upon cell-mediated immune (CMI)
responses (1.128).

Humoral immune responses have little or

no protective effect (1.128).

Immunity to paratuberculosis

is probably dependent upon the activation of antigenspecific T cells that induce the CMI response of
mononuclear phagocytes, resulting in macrophage activation
and killing of phagocytized mycobacteria (1.128).

In

tuberculosis, both CMI and delayed-type hypersensitivity
(DTH) play a role in mycobacterial clearance (1.129).

The

CMI is responsible for macrophage activation resulting in
the destruction of ingested bacilli, while the DTH response
results in tissue necrosis and the destruction of
mycobacterial infected macrophages, releasing them from
their protected intracytoplasmic environment (1.129).
Although some tissue necrosis is reported in the infected
tissues of small ruminants (deer, sheep, and goats) the DTH
response is absent in the intestinal tissues of infected
cattle and probably does not play as significant a role in
resistance to the infection in the target tissues (1 .2 ).
Although DTH responses in the skin occur in some cattle
with paratuberculosis (1.2,1.26-30), this phenomenon does
not appear to occur in the tissues where the organism
resides (1.128).

This is probably due to the

compartmentalization of the gut-associated lymphoid tissues
(GALT) (1.128) .
Paratuberculosis is unique in that proliferation of
the organism is usually limited to the intestinal tissues
and associated lymph nodes, and resistance to the organism
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is therefore probably under the exclusive control of the
GALT (1.128).
The GALT are believed to operate differently from the
systemic immune system (1.128).

Sometimes the GALT immune

response is actually opposite to the systemic response
(1.130).

Evidence for this is the oral tolerance

phenomenon, which suppresses the systemic immune system to
orally presented antigens (1.130).

Furthermore, the immune

response of the GALT is essentially compartmentalized
(1.128).

Although lymphocytes primed in the intestinal

tissues transiently circulate, they will eventually return
to the tissues in which they were activated (1.131).
Lymphocytes that encounter antigen either in the lamina
propria or Peyer's patches of the intestine will
temporarily leave the intestines, drain to the mesenteric
lymph nodes, and eventually reach the systemic circulation
(1.128,1.131).

These cells will eventually, however,

return to the intestinal tissues and disperse throughout
the mucosa, resulting in the spread of these specific
antigen-activated lymphocytes throughout the intestinal
tract (1.128,1.131).

This cellular homing to the tissues

of origin is dependent upon specific cell surface homing
receptors that bind to complementary ligands expressed on
high endothelial venules (HEV)

(1.131).

This homing

results in specifically primed lymphocytes being returned
to the tissues from where the antigen was first
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encountered, probably as a means of both conserving immune
cells, and of targeting the specific tissues where the
antigen is present.
There are unique features of the GALT of ruminants
that may play a key role in the unique susceptibility of
these animals to Mycobacterium paratuberculosis infection
(1.128).

Although all mammals have Peyer's patches, the

Peyer's patches of ruminants are unique compared to those
of other animals in that there are two different types
(1.128.1.132).

The jejunal Peyer's patches are similar to

those of other species in that they are not present until
after birth and seem to develop in response to antigenic
stimulus (1.128,1.132).

The ileal Peyer's patches, on the

other hand are thought to be a primary lymphoid organ
similar to the bursa of Fabricus in birds, which is
important in the generation of lymphocytes, rather than
simply being the sites of lymphocyte activation or priming
(1.128.1.132).

If so, the generation of lymphocytes in

these areas may be important in the pathogenesis of
disease.

If, for example, foreign antigens such as

mycobacteria or other infectious agents are encountered
during the developmental stages of lymphocytes, they may
fail to recognize these antigens as foreign, and become
tolerant to them.

Another possibility is that

mycobacterial antigens induce a state of immunologic
unresponsiveness in the intestines via mechanisms similar
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to those involved in the oral tolerance phenomenon (1.128).
This are two hypotheses that could explain the enhanced
susceptibility of young calves to paratuberculosis.
Gamma Delta T Cells and Mycobacterial Disease
In most animal tissues, the vast majority of T cells
express a heterodimer consisting of two polypeptide chains
referred to as the alpha/beta T cell receptor (aj8 TCR)
(1.133).

This receptor serves as the antigen recognition

and binding site for the cell (1.133).

Included amongst

the a/3 T cells are the T cell subsets commonly referred to
as the helper/inducer (CD4+) T cells and most of the
cytotoxic/suppressor (CD8 +) T cells.

However, in 1984, a

second subset of T cells were identified that express a
unique set of polypeptide subunits, now referred to as the
gamma/delta T cell receptor (7 S T C R ) (1.134).

These cells

differ in many respects from the a/3 T cells with regard to
their ontogeny, side-chain diversity, and anatomic location
(1.135).

Although little is presently known about the

functional characteristics of these cells, their prominence
in epithelial surfaces strongly suggests that they play a
role in the surveillance of the mucosal epithelium to
invading pathogens (1.135,1.136).
To date,

7

S T cells have been found in every species

in which they have been sought (1.137).

In most species,

including mice and humans, these cells are found almost
exclusively in the intestinal tract and epithelial surfaces
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(1.135,1.137).

Young ruminants, however, have strikingly

different proportions of circulating yS T cells compared to
other species (1.138).
lymphocytes of
(1.138).

Up to 75% of the total circulating

2 -week-old

ruminants are yS+ T cells

The prominence of yS T cells in these ruminants

decreases with age, as three month old animals have
peripheral lymphocyte percentages measuring 30%, and those
5 and 10 years of age have peripheral yS T cell proportions
of 10% and 5% respectively (1.138).

Although it may be

incidental, the prominence of this cell population in the
ruminant might prove to be important in the susceptibility
and/or pathogenesis of Mycobacterium paratuberculosis.
Since their discovery, several studies have implicated
an involvement for yS T cells in the immune response to
mycobacteria (1.139-1.141).

In vivo experiments have

demonstrated up to 28-fold increases in the numbers of yS T
cells in the draining lymph nodes of mice vaccinated with
M. tuberculosis in Freund's adjuvant (1.139).

Increased

numbers of yS T cells have also been detected in the lungs
of mice aerosolized with mycobacterial purified protein
derivative (PPD)

(1.142).

Increased numbers of yS T cells

can also be found in the skin of certain types of leprosy
lesions (1.143).

Furthermore, several studies have shown

proliferative responses of yS T cells to mycobacterial
products or their fractions (1.140-1.146).
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Although there is a clear association between
mycobacterial diseases and yS T cells, little is known
about the role these cells play in infection.

Since the

majority of these cells reside in or near epithelial
surfaces, it has been suggested they may play a protective
role against pathogens that may be encountered in damaged
epithelium (1.135,1.137).
The majority of yS T cells from the intestinal
epithelial lymphocyte (IEL) population also co-express CD 8 ,
suggesting they may play a cytotoxic role, and cytotoxic
activity of these IEL's has been demonstrated both in vivo
and in vitro (1.147).

Furthermore, IEL derived yS T cells

are capable of reversing orally induced systemic
unresponsiveness to certain antigens (sheep red blood
cells) when adoptively transferred to mice orally tolerized
with these antigens (1.147).

However, both IL-5 and IFN - 7

production has been demonstrated by murine

75+

IEL's,

suggesting that they may also play a helper or regulatory
role (1.148).

This suggests that

7

S T cells of the IEL

population may have properties of both Thl and Th2 type
effector cells.
Lymphocytes expressing the

7

S TCR isolated from

extra-intestinal sources have different properties than
those from the IEL's (1.148-150).
different gene usage between

7

and those of the skin (1.149).

First, there is

S T cells of the intestine
In addition, co-expression

of both CD 8 and yS TCR seems to be limited to the IEL's, as
CD 8 +, yS TCR+ (double-positive) cells are rare in epidermal
or extraintestinal tissues (1.149).

Furthermore, yS T

cells from the intestines seem to be generated from within
the intestinal tissues, whereas all other yS T cells (and
other known T cells) are derived from the thymus (1.149).
Finally, differences in cytokine production have been
demonstrated between yS T cells of the IEL's and those from
other tissues (1.148,1.150).

Gamma/delta T cell lines

derived from lymph nodes can produce IL-2, IL-3, GM-CSF,
and IFN-y (1.150).

These y<S+ T cell lines do not produce

IL-4 nor IL-5, suggesting that they play more of a Thl type
role (1.150).

On the other hand, these cell lines do

express the IL-4 receptor (IL-4Rc) and require IL-4
stimulation to transfer delayed-type hypersensitivity
reactions in the skin (1.150).
Objectives
The immunological reactions that occur throughout the
course of infection with M. paratuberculosis have not been
evaluated.

Economics is one of the major reasons for this,

since the long incubation period of the disease, combined
with the cost of maintaining a significant number of
infected cattle is cost prohibitive for most investigators.
Previous attempts to define a suitable laboratory animal
model for paratuberculosis,

(many of which were performed

over 40 years ago) were often contradictory and confusing.
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However, developments in genetic technology, the
development of inbred mouse strains, and recent advances in
the pathogenesis of other mycobacterial diseases have shown
that mycobacterial resistance has a genetic component,
which may explain earlier failures to infect mice.

Recent

evidence suggests that immunity to Mycobacterium
paratuberculosis in mice may also be genetically linked and
that once defined, mice may be a suitable laboratory animal
model for studying paratuberculosis.
Objective 1
To demonstrate that resistance to M. paratuberculosis.
like other mycobacterial diseases, is associated with the

Beg gene by showing that bacterial clearance occurs in a
Beg resistant mouse strain, while bacterial proliferation
occurs in a susceptible strain.
Objective 2
To demonstrate that susceptible mouse strains
eventually develop lesions resembling those of the natural
disease in ruminants and therefore may be used as a
suitable model for studying the pathogenesis of the disease
in all stages of the infection.
Objective 3
To determine whether immunological differences exist
between the two strains of mice in response to infection
with M. paratuberculosis using the following immunologic
techniques and methods:

a) Measurement of levels of non-specific macrophage
activation in response to the infection by use of a
Listeria sp. challenge assay.
b) Evaluation of the kinetics of the T cell response
throughout the course of the infection in several
immunologic organs to determine whether there are
significant differences in the proportions of CD3 , C D4,
CD 8 , and/or yS T cells between the two strains of mice in
response to infection.
c) Determination of changes in levels of lymphocyte
activation in response to the infection by assessing the
percentages of CD44+ and CD25+ cells responding to the
infection.
d) Determination of differences in the production of IL-2
and/or IL-4 in response to exposure of cells of each mouse
to M. paratuberculosis in vitro.
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CHAPTER 2.

COMPARATIVE SUSCEPTIBILITY OF C57BL/6 AND
C3H/He MICE TO INFECTION WITH
MYCOBACTERIUM PARATUBERCULOSIS
Introduction

Paratuberculosis (Johne's disease)
granulomatous,

is a chronic,

intestinal disease of ruminants caused by

the acid-fast bacterium Mycobacterium paratuberculosis.
Clinically, the disease is characterized by progressive
weight loss and intractable diarrhea (2.1). Ruminants are
infected at a young age, but several months to years may
elapse before clinical signs are detected (2.1).

The

disease occurs throughout the world and is endemic in the
United States (2.1).

Estimates of the prevalence in this

country range from 3-17% in culled dairy cattle (2.1).
The lack of a suitable laboratory animal model for
ruminant paratuberculosis has hampered research into the
immunology and pathogenesis of this disease.

The

literature on the susceptibility of laboratory animals to
M. paratuberculosis is confusing and often conflicting
(2.1,2.3).

Failure to successfully infect cats, guinea

pigs, mice, rabbits, rats, hens, pigeons,
hamsters with

gerbils, and

paratuberculosis (or M-_ iohnei) has been

reported (2.3-2.14).

Some researchers were successful in

infecting one species but failed with another, while others
could not duplicate some of these infections.
Much of the confusion in the use of mice and rabbits
may now be explained by the variable susceptibility of
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animals with different genotypes to mycobacterial
infections.

It is now known that resistance to several

mycobacterial infections in mice and rabbits is associated
with the Beg gene (2.15-2.17).

Previous failures to infect

these animals with M. paratuberculosis might have been due
to the inadvertent use of genotypically resistant strains
of animals.

Rabbits have recently been shown to be an

acceptable laboratory animal model for studying the entry
and pathogenesis of paratuberculosis (2.18), but the lack
of commercially available reagents to lymphocytes in the
rabbit make this a less than optimal model for studying the
immune responses to the infection.
The comparative susceptibility of C57, CBA, and Swiss
mice to an intraperitoneal infection with M.
paratuberculosis has been reported (2.19).

These

experiments showed that C57 mice were more susceptible to
infection, with Swiss mice being less so, and CBA being
relatively resistant (2.19).

Later experiments, in

contrast, failed to demonstrate successful infection of C57
mice using an oral route of inoculation (2.20).

This may

be explained by the use of genetically undefined mice.

It

is now known, for example, that the inbred mouse strains
designated C57BL/6 and C57BL/10 are Beg susceptible, yet
C57BR and C57L are Beg resistant (2.21).

In addition, the

duration of the infection in question was terminated at 9
months, and more importantly, the mesenteric lymph nodes,

55
which proved to be of particular importance in the present
studies, were not examined (2.20).
The susceptibility of C3H/HeJ, C57BL/6J, and a number
of recombinant inbred strains of mice to an intravenous
infection with M. paratuberculosis has also recently been
compared, using the number of hepatic granulomas as an
index (2.16).

A correlation was shown between the Beg

genotype and susceptibility to the infection as determined
by histologic counts of liver granulomas developing after
50 days of infection (2.16).

Although actual bacterial

numbers were not determined, this study determined that
early resistance to M. paratuberculosis. like other
mycobacterial diseases, is associated with the Beg gene.
The gut associated lymphoid tissues (GALT) were not
examined in this study, and therefore no comparisons to the
natural disease were made.

Furthermore, the study was

terminated at 50 days postinoculation (2.16), and it was
not determined whether the infection would have progressed
or have been self-limiting in those mice.
The objectives of the present study were to determine
whether there were significant differences in the lesions
and/or persistence of Mycobacterium paratuberculosis in a

Beg susceptible (Beg3) mouse strain (C57BL/6) compared to a
Beg resistant (Begr) strain (C3H/He) over a 9 month period
of infection.

To accomplish this, both strains of mice

were infected with a high, intraperitoneal (ip) dose of M.
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paratuberculosis and incubated at intervals extending up to
9 months.

At the end of the study, the mice were

sacrificed and M. paratuberculosis colony forming units
(MCFU) from the spleens were counted.

The small and large

intestines, mesenteric lymph nodes, livers, lungs, kidneys,
and peritoneal granulomas were also examined
microscopically for the presence of granulomatous lesions
containing mycobacteria.

For confirmation of the

mycobacteria, immunohistochemistry was performed on tissues
containing acid-fast organisms using an anti-Mvcobacterium
paratuberculosis polyclonal antibody.
Materials and Methods
Animals
Both the C3H/HeN and C57BL/6N mice used in this study
were originally obtained from Harlan Sprague Dawley, Inc.,
Indianapolis, IN, and bred at the AAALAC accredited,
Louisiana State University, Division of Laboratory Animal
Medicine Vivarium.

Mice were housed in polypropylene

rodent boxes ("shoebox" cages) with stainless-steel wire
tops, on heat-treated, aspen-chip bedding (Sani-Chips, P.J.
Murphy Forest Products Corp., Montville NJ ) .

Animals were

fed Purina Rodent Chow 5001 (Purina Mills, Inc., St. Louis,
MO) and water ad libitum, and maintained on a 12/12-hour
light/dark cycle.

All mice used in the study were infected

at 4-6 weeks of age.
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Organism and Preparation of Inoculum
Mycobacterium paratuberculosis ATCC strain 19698 was
obtained from the USDA-ARS, National Animal Disease Center
(NADC) Ames, Iowa and grown in Middlebrook 7H9 broth
supplemented with Middlebrook OADC enrichment media (DIFCO
labs, Detroit MI), 0.2% glycerol (Sigma, St. Louis, MO),
and 2 mg/liter Mycobactin J (Allied Laboratories, Glenwood
springs, C O ) .

Broth cultures were incubated at 37°C for 3-

5 months and bacteria were harvested by centrifugation (10
minutes at 2 000g), washed 3X in phosphate-buffered saline
(PBS), sonicated for 10 seconds at 40W (Heat SystemsUltrasonics Inc., Plainview, N.Y.) to reduce clumping, and
adjusted to 3 X 109 bacteria per dose as determined by
McFarlands standards.

The number of viable bacteria per

inoculum was later verified by plating serial dilutions on
Middlebrook 7H10 agar supplemented with OADC and Mycobactin
J.

Mice were inoculated by the intraperitoneal route with

1 X 109 viable bacilli suspended in 0.3ml PBS.
Susceptibility Assays
Bacterial CFU from the spleens of infected mice were
counted after postinoculation intervals ranging from 3 days
up to 11 months (Table 2.1).
least 4 mice.

Each group consisted of at

For bacterial counts, mice were killed by

cervical dislocation and spleens were aseptically removed
and placed in 3ml RPMI-1640 on ice.

Spleens were

homogenized using pestle-type tissue homogenizers (Thomas
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Scientific, Swedesboro, NJ ) , and serial dilutions were
plated on Middlebrook 7H9 agar supplemented with OADC and
mycobactin-J.

Plates were then sealed in plastic bags and

incubated at 37°C in a humidified incubator.

Bacterial CFU

were counted after 4 weeks of incubation using a colony
counter (New Brunswick Scientific, N J ) .
Statistical Analysis
Mycobacterial counts were computer analyzed by
comparative analysis of variance using Tukeys' studentized
range test.

Least square means were compared between each

group of mice using a pairwise t test.

Groups at different

infection intervals were compared within strains, and those
at the same infection interval were compared between
strains.
Gross and Microscopic Pathology
Samples of liver, jejunum, ileocecal valve, colon,
mesenteric lymph nodes, and peritoneal granulomas (when
present) were taken from mice that had been inoculated at
intervals of 5, 10, 15, 30, 226, and 269 days.

Tissues

were fixed in neutral-buffered 10% formalin, and routinely
paraffin-embedded, sectioned, and stained with H&E and
Ziehl-Neelsen acid-fast stains.

Liver sections were taken

from the widest part of the left lobe and mesenteric lymph
nodes were sectioned longitudinally.

At least one
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centimeter of each intestinal segment (jejunum, ileum, and
colon) was examined histologically from each mouse.
Immunohistochemistry
Formalin-fixed tissues were routinely embedded in
paraffin and sectioned at 4/xm.

Sections were attached to

silanized slides, dried overnight at 37°, deparaffinized
through zylene and graded alchohols, and then equilibrated
with tris-buffered saline.

Sections were then stained

using the avidin-biotin complex method with rabbit, antiMvcobacterium paratuberculosis polyclonal antibody (Dako,
Carpinteria, CA).
Results
Microbiology
Equal numbers of viable M. paratuberculosis bacilli
(as determined by CFU counts) were isolated from the
spleens of both strains of mice after 3 days of infection
(Fig. 2.1). Thereafter, the numbers of mycobacteria
isolated from the Bcgr mice (C3H/He) decreased over the
course of infection (Fig. 2.1).

Significant decreases

(p<0.05) in the number of bacterial CFU's were detected in
C3H/He mice that had been infected for 10 days compared to
those infected for 3 days.

By 6 months after infection,

bacterial numbers in the Bcgr strain had dropped over 100fold.

In contrast, no significant decreases in bacterial

CFU's were observed in the Beg* (C57BL/6) strain.

In fact,

bacterial counts from chronically infected C57BL/6 mice
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Figure 2.1.
Comparison of the growth of Mycobacterium
paratuberculosis in the spleens of Beg resistant (C3H/He)
and Beg susceptible (C57BL/6) strains of mice.
Each point
represents the mean CFU of 3-9 mice.
Error bars represent
the standard error of the mean.
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were consistently higher than those that had been infected
for 3 days (Fig. 2.1).
Gross Pathology
Peritoneal granulomas were consistently present in all
mice that had been infected for more than 10 days but less
than 5 months.

These granulomas were usually small (up to

3mm diameter), white to yellow, firm, and were usually
adhered to the peritoneal wall, intestinal serosa, surface
of the liver, omenta, or diaphragm.

Adhesions between the

intestines, spleen, stomach, and/or liver were frequent.
Mesenteric lymph nodes from C57BL/6 mice infected over
5 months were often enlarged and firm compared to those
from C3H/He mice.

Marked splenomegaly was present by 10

days after infection in both strains of mice but this
usually subsided by 30 days after infection. Interestingly,
the spleen and Peyer's patches were usually 3-4X larger in
both control and infected C3H/He mice than in the C57BL/6
strain.
Microscopic Pathology
Marked differences were observed between infected
C3H/He mice and C57BL/6 mice in the lesions that developed
in response to the infection.

Numerous (5-10 per mm2)

granulomas associated with acid-fast bacteria were detected
in the livers of C57BL/6 mice that had been infected for 10
days or more, whereas significantly fewer (less than 2 per
mm2) granulomas were detected in the livers of C3H/He mice
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of the same pi intervals (Fig. 2.2).

Liver lesions in Bcgs

mice were first evident in the 10 day pi group, and peaked
in size (up to 200jum in diameter) and number at 15 days of
infection.

Hepatic granulomas were centered around portal

veins and consisted of mixtures of neutrophils,
lymphocytes, macrophages, and multinucleated giant cells
(Fig. 2.2).

Several (4-6 per mm2) smaller microgranulomas

containing acid-fast bacilli were still present in C57BL/6
mice that had been infected for 9 months but liver lesions
were essentially absent in chronically infected C3H/He
mice.
Marked strain differences in the lesions of the
mesenteric lymph nodes were also detected in infected mice
(Fig. 2.3).

Granulomatous mesenteric lymph node (MLN)

lesions were consistently present in C57BL/6 mice that had
been infected for 30 days or more, whereas lesions were
absent or minimal in C3H/He mice (Fig. 2.3).

Severe

granulomatous lesions containing numerous acid-fast
bacteria were observed in all C57BL/6 mice infected for 6
months or more.

Occasionally, mild granulomatous lesions

were observed in the MLN of C3H/He mice infected for 6
months or less, but these had completely resolved in the 9
month pi group.
Histological examination of the peritoneal granulomas
at 5 days pi revealed centers of necrotic cell debris,
neutrophils, and acid-fast bacteria surrounded by an
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Figure 2.2.
Photomicrographs comparing the liver of a
resistant (C3H/He) mouse (A) to that of a susceptible
(C57BL/6) mouse (B) 15 days after an intraperitoneal
infection with 1 X 109 viable Mycobacterium
paratuberculosis organisms.
Note the numerous hepatic
granulomas (arrows) in the liver of the susceptible mouse.
H&E stain, bar = 100fim.

Figure 2.3.
Photomicrographs comparing the mesenteric
lymph node of a resistant (C3H/He) mouse (A) to that of a
susceptible (C57BL/6) mouse (B) 9 months after an
intraperitoneal infection with 1 X 109 viable Mycobacterium
naratuberculosis. The susceptible mouse has marked
granulomatous inflammation consisting of numerous
aggregates of macrophages and multinucleated giant cells
(arrows) . H&E stain, bar = 100/m.

intense zone of macrophages and lymphocytes.

By 30 days

pi, the granulomas were laminated, with centers containing
colonies of extracellular, acid-fast bacteria immediately
surrounded by a zone of necrotic cell debris and
neutrophils, which was further surrounded by a thick band
of foamy macrophages (Fig. 2.4).

Numerous lymphocytes and

fibroblasts were present around the periphery of these
granulomas.

Macrophages in the granulomas contained

numerous acid-fast bacilli.

By 6 months, the granulomas

had resolved into cores of dense, mature fibrous tissue and
collagen.

Macrophages containing acid-fast bacilli were

still observed in the centers of these granulomas in both
mouse strains.

No histopathological differences were

detected between the granulomas of the two mouse strains.
Discussion
Paratuberculosis in ruminants is due to the
persistence and proliferation of Mycobacterium
paratuberculosis bacilli in the intestine and mesenteric
lymph nodes of infected cattle (2.1,2.22-23).

The disease

has a long incubation period, as several months to years
may elapse between the time calves are infected and
clinical signs occur (2.1,2.22).

Although no breed

predisposition has been proven, it is estimated that only
1/3 of the young animals exposed to the bacillus become
chronically infected (2.1).

Little is known about the

immunology and resistance to the organism, partially due to
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Figure 2.4.
Photomicrograph of a granuloma in the
peritoneum of a C57BL/6 mouse 30 days following an
intraperitoneal infection with 1 X 109 viable Mycobacterium
paratuberculosis. H&E stain, bar = lOOjxm

67
the lack of an acceptable laboratory animal model.

Studies

on the pathogenesis and immunology or paratuberculosis in
the natural host (ruminants) are limited by the high cost
of maintaining a statistically significant number of large
animals throughout such an extended incubation period.

If

determined to be suitable, the use of smaller laboratory
animals could benefit research into paratuberculosis.
The results of this study document and quantify
differences in the susceptibility between C57BL/6 and
C3H/He mice to infection with Mycobacterium
paratuberculosis.

Mice having the Bcgr genotype (C3H/He)

were able to either kill or at least prevent the
proliferation of M. paratuberculosis over a 9 month course
of infection, as determined by the continually declining
numbers of mycobacterial CFU isolated from the spleens.

In

contrast, bacterial proliferation occurred in the Beg*
strain (C57BL/6), as CFU were consistently higher in
spleens from chronically infected mice compared to those
infected for only 3 days.

Furthermore, marked differences

in the lesions were noted between these two strains of
mice.

Susceptible mice (C57BL/6) developed granulomatous

lesions in the mesenteric lymph nodes resembling those
observed in the natural disease of ruminants (Figure 2.3).
These lesions continually increased in severity over the
course of the infection.

In contrast, no evidence of

infection was detected in resistant (C3H/He) mice after 9
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months of infection.

Marked differences in the number of

hepatic granulomas that developed in the two strains of
mice were also observed, which has previously been
documented (2.16).
Intestinal lesions were not detected in any of the
infected mice.

Mesenteric lymph node lesions precede the

development of intestinal lesions in ruminants
experimentally infected with Mycobacterium paratuberculosis
(2.24).

The progressive nature of the mesenteric lymph

node lesions in the C57BL/6 mice suggested that intestinal
lesions may eventually have developed had the infection
period been extended.

The incubation period of the natural

disease ranges from several months to years (2.1), and the
lack of intestinal lesions in these mice is probably due to
the termination of the experiment at 9 months.

Previous

reports have shown that, given enough time, intestinal
lesions eventually occur in susceptible mice (2.3,2.19).
Although a marked reduction in bacterial numbers was
observed in Bcgr mice, complete bacterial clearance did not
occur in any of the mice over the 9-month course of
infection.

It is uncertain as to whether bacterial

clearance would have occurred in the resistant strain had
the duration of the experiment been extended.

Since all

detectable lesions due to the infection had resolved in
this strain by 9 months pi, it is possible that the
bacteria would have eventually been cleared as well.

The results confirm that resistance to M.
paratuberculosis. like other mycobacterial infections, is
associated with the Beg gene, and that bacterial
proliferation occurs in a susceptible mouse strain
(C57BL/6) over a protracted (9 month) course of infection.
Furthermore, progressive lesions resembling those of the
natural disease in ruminants develop in these mice over the
course of the infection.
These results suggest that genetically susceptible
(Bcgr8) strains of mice may be used as an appropriate
laboratory model for studying the entry, development of
lesions, and other aspects of the pathogenesis of Johne's
disease.

However, only two strains of mice were examined

in this study.

Additional research is needed to determine

whether all Beg 8 mice may be used as a model of Johne's
disease.
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CHAPTER 3.
HISTOPATHOLOGY OF C57BL/6 MICE ORALLY INFECTED
WITH MYCOBACTERIUM PARATUBERCULOSIS; LESIONS IN
SUSCEPTIBLE MICE RESEMBLE THOSE IN RUMINANTS
Introduction
Paratuberculosis (Johne's disease)

is a chronic,

granulomatous, intestinal disease of ruminants caused by
the acid-fast bacterium Mycobacterium paratuberculosis.
Clinically, the disease is characterized by progressive
weight loss and intractable diarrhea (3.1). Ruminants are
infected at a young age, but several months to years may
elapse before clinical signs occur (3.1).

The disease

occurs throughout the world and is particularly prevalent
in domestic livestock (3.1).

Estimates of the prevalence

of paratuberculosis in the United States range from 3-17%
in culled dairy cattle (3.2).
The lack of a suitable laboratory animal model for
paratuberculosis has hampered research into the immunology
and pathogenesis of this disease.

Rabbits were the first

laboratory animals shown to develop classical lesions of
Johne's disease (3.3,3.4).

Thickening and corrugation of

the intestinal mucosa due to infiltration of epithelioid
cells filled with acid-fast bacilli were observed in 25% to
45% of rabbits within 3 to 18 months postinoculation
(3. 3, 3.4).

Unfortunately, other attempts to inoculate

rabbits often failed, suggesting that rabbits were
resistant to infection (3.5,3.6 ).

This inconsistency may

have been due to variations in the strains of rabbits
72
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and/or bacilli used.

It is now known that resistance to

mycobacterial diseases in rabbits is under genetic control,
and rabbits may be selectively inbred for their
susceptibility or resistance to these infections (3.7).
Since the discovery of this genetic association followed
early paratuberculosis experiments with rabbits, it is
likely that unsuccessful attempts were due to the
inadvertent use of genetically resistant rabbits.
More recently,

it has been shown that New Zealand

white rabbits may be orally infected with Mycobacterium
paratuberculosis. resulting in granulomatous intestinal
lesions resembling those of the natural disease in
ruminants (3.8).

Intestinal lesions resembling

paratuberculosis have also been described in a wild rabbit,
suggesting that at least some rabbits may be naturally
susceptible to the disease (3.9).

Unfortunately, the lack

of commercially available immunologic reagents in the
rabbit make it difficult to study the immunology of
paratuberculosis in this species.
Information on the susceptibility of mice to M.
paratuberculosis is confusing and often conflicting (3.23,3.5-6,3.10).

As in the rabbit, much of this confusion

may be explained by the variable susceptibility of
different mouse strains to mycobacterial infections
(3.7,3.11-12).

It is now known that resistance to

mycobacterial infections in mice, like rabbits, is
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associated with the Beg gene (3.7,3.11,3.12).

Previous

failures to infect mice with M. paratuberculosis may have
been due to the inadvertent use of genotypically resistant
mice.
The comparative susceptibility of C57, CBA, and Swiss
mice to an intraperitoneal infection with M.
paratuberculosis has been reported (3.13).

These

experiments showed that C57 were more susceptible to
infection, with Swiss mice being less so, and CBA being
relatively resistant.

Later experiments,

in contrast,

failed to demonstrate successful infection of C57 mice
using an oral route of inoculation (3.14).

This might be

explained by the use of genetically undefined mice.

It is

now known, for example, that the inbred mouse strains
designated C57BL/6 and C57BL/10 are Beg susceptible (Beg*) ,
yet C57BR and C57L are Beg resistant (Beg1) (3.15) .

In

addition, the duration of the infection in question was
terminated at 9 months, and more importantly, the
mesenteric lymph nodes, which proved to be of particular
importance in the present studies, were not examined
(3.14),.
More recent studies indicate that murine
susceptibility to M. paratuberculosis. like other
mycobacterial diseases, is also associated with the Beg
gene (3.11).

A correlation was shown between the Beg

genotype and susceptibility to paratuberculosis infection
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as determined by comparative hepatic granuloma counts 50
days after an intravenous infection with M.
paratuberculosis (3.11).

Although the numbers of viable

bacteria were not determined, this study did indicate that
early resistance to paratuberculosis, like other
mycobacterial diseases, is associated with the Beg gene
(3.11).

The study was terminated at 50 days p.i., and the

gut associated lymphoid tissues (GALT) were not examined,
and therefore no comparisons to the natural disease were
made.
The objective of this experiment was to determine
whether a Begs strain of mice (C57BL/6N) could be
successfully infected with M. paratuberculosis using an
oral route of administration.

Mice were inoculated via

gastric gavage with 3 X 10n CFU of Mycobacterium
paratuberculosis strain 19698 suspended in cream.

The GALT

and other tissues were histologically evaluated for the
presence of lesions and acid-fast bacteria after
postinoculation intervals of 7,8,9, and 11 months.
Materials and Methods
Mice
All mice used in the experiments were bred from a
C57BL/6N breeder colony originally obtained from Harlan
Sprague Dawley Inc., Indianapolis, IN, and bred at the
AAALAC accredited, Louisiana State University, Division of
Laboratory Animal Medicine Vivarium.

Mice were housed in

polyprdpylene rodent boxes ("shoebox" cages) with
stainless-steel wire tops, on heat-treated, aspen-chip
bedding (Sani-Chips, P.J. Murphy Forest Products Corp.,
Montville N J ) .

Animals were fed Purina Rodent Chow 5001

(Purina Mills, Inc., St. Louis, MO) and water ad libitum,
and maintained on a 12/12-hour light/dark cycle.

All mice

were infected at 4 weeks of age and then weaned.
Uninfected control mice were housed in separate cages using
identical husbandry conditions.
Organism and Preparation of Inoculum
Mycobacterium paratuberculosis ATCC strain 19698 was
obtained from the USDA-ARS, National Animal Disease Center
(NADC) Ames, Iowa and grown in Middlebrook 7H9 broth
supplemented with Middlebrook OADC enrichment media (DIFCO
labs, Detroit MI), 0.2% glycerol (Sigma, St. Louis, MO),
and 2 mg/liter Mycobactin J (Allied Laboratories, Glenwood
springs, CO).

Broth cultures were incubated at 37°C for 3-

5 months and bacteria were harvested by centrifugation (10
minutes at 2000g), washed 3X in phosphate-buffered saline
(PBS), sonicated for 10 seconds at 40W (Heat SystemsUltrasonics Inc., Plainview, N.Y.) to reduce clumping, and
adjusted to 3 X 1011

paratuberculosis per dose as

determined by a McFarlands nephelometer standard.

Each

dose was suspended in 0.3ml of cream and administered
orally by gavaging with a ball-tipped needle.

The number

of viable bacteria per inoculum was later verified by
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plating serial dilutions on Middlebrook 7H10 agar
supplemented with OADC and Mycobactin J.
Histologic Examinations
Animals were killed by cervical dislocation at 7,
9, and 11 months after infection.

8

,

Liver, spleen, duodenum,

jejunum, ileocecal valve, colon, and mesenteric lymph nodes
were fixed in neutral-buffered 10% formalin.

At least one

cross-section of liver (taken from the widest part of the
left lobe), spleen, and at least one centimeter of each
intestinal segment (duodenum, jejunum, ileum, and colon)
were examined histologically from each mouse.

A few

mesenteric lymph nodes were lost during processing and
therefore not examined.

Tissues were routinely paraffin

embedded and 5jum sections were stained with H&E and ZiehlNeelsen acid-fast stains, and examined by light microscopy.
Immunohistochemical techniques were applied to tissue
sections containing acid-fast bacteria.

Formalin-fixed,

paraffin-embedded tissues were sectioned and stained by the
amino-ethylcarbazole (AEC) method using using rabbit antiMvcobacterium paratuberculosis polyclonal antibody (Dako
Inc., Carpinteria, CA).
Results
A total of 18 out of 31 (58%) orally inoculated mice
were found to have demonstrable acid-fast bacteria in their
tissues.

The infection was most often limited to the

mesenteric lymph nodes.

Of the 26 mesenteric lymph nodes

examined, 17 (65%) were found to be infected (Table 3.1).
Acid-fast bacteria were found in the 3 of the livers and 3
of the spleens (in 5 mice).

Immunohistochemical staining

of infected tissue sections with rabbit anti-Mvcobacterium
paratuberculosis antibody confirmed that the organisms were
mycobacteria.

No lesions or acid-fast bacteria were

present in the intestines of any of the mice.
The severity of the lesions in the infected mesenteric
lymph nodes varied, but multinucleated giant cell formation
was a consistent finding.

The most severely affected nodes

were observed in those mice that had been inoculated for
months (Fig. 3.1).
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In these nodes, the normal follicular

architecture was effaced by pale, swollen macrophages and
multinucleated giant cells containing numerous acid-fast
bacteria (Fig. 3.1).

A few lymph nodes had moderate

infiltrations of neutrophils associated with the bacteria.
Liver lesions consisted of microgranulomas comprised of
small, periportal clusters of infected macrophages
containing mycobacteria, surrounded by a few lymphocytes
and neutrophils.

Larger granulomas consisting

predominantly of lymphocytes and fewer numbers of
macrophages were often present around portal triads, but no
acid-fast bacteria could be demonstrated in these.

No

acid-fast bacilli or related lesions were detected in the
control mice.

Table 3.1. Results of histological examinations of C57BL/6 mice orally infected with
Mycobacterium paratuberculosis.

P.I.
INTERVAL 8

*

PRESENCE OF LESIONS AND
ACID FAST BACTERIA
MESENTERIC
LYMPH NODE

SPLEEN

LIVER

INTEST

11 MONTHS

6

4 (n=4)*

1

1

0

9 MONTHS

4

1

(n=2 )*

1

1

0

MONTHS

12

7

0

0

0

7 MONTHS

9

6

1

1

0

8

a

NUMBER
OF MICE
EXAMINED

Postinoculation interval following an oral infection with Mycobacterium
paratuberculosis.
Some mesenteric lymph nodes were lost in process and therefore not examined.

Figure 3.1. Mesenteric lymph node of a C57BL/6 mouse
eleven months after an oral infection with Mycobacterium
paratuberculosis (A). Note the extensive infiltration of
macrophages (arrows) . H&E stain, bar = lOOjxm. .
B: Higher magnification of the same lymph node
demonstrating that the macrophages are engorged with acidfast bacilli.
Ziel Neelsens acid-fast stain.
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Discussion
Research into the immunology and pathogenesis of
ruminant paratuberculosis has been slow due to the lack of
an acceptable laboratory animal model for the disease.
Several attempts to inoculate mice and other laboratory
animals with Mycobacterium paratuberculosis were made in
the first half of this century,

(3.3-4,3.5-6, 3.10,3.16),

but the results of these studies varied and were often
contradictory.

Since these studies were performed,

advances have been made in our understanding of the genetic
susceptibility to mycobacterial infections.

This may

explain some of the previous failures to experimentally
inoculate laboratory animals with mycobacteria and certain
other intracellular pathogens (3.7, 3.12, 3.15).

The

selection and use of animal strains of a specific,
susceptible genotype (Bcgs) is required to reproduce the
typical lesions and progressive infections associated with
mycobacterial diseases (3.7, 3.11, 3.12).
In contrast to previous reports (3.14), this
experiment documents a successful infection rate (over 58%)
of C57BL/6 mice with a commonly available strain of M.
paratuberculosis using an oral route of administration.
The actual number of infected animals in this study may
have been underestimated due to the methods employed and
the termination of the experiment at 11 months.

Many of

the mesenteric lymph nodes had limited, focal infections,
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suggesting that some infected animals may have been missed.
Others may have been missed if bacteria had not yet
multiplied to sufficient numbers for detection.

The

incubation period of the natural disease ranges from
several months to years (3.1) and this may also be the case
in murine infections.
An important finding in this study is the observation
that almost all of the lesions and detectable mycobacteria
were in the mesenteric lymph nodes.

Furthermore, the

severity of the lesions correlated with the duration of
infection.

Since intestinal lesions were not found in any

of these mice, this suggests that the organisms replicate
in the mesenteric lymph nodes before proliferating in the
intestines.

Mesenteric lymph node lesions also precede

intestinal lesions in ruminants with paratuberculosis
(3.17).

Although M^. paratuberculosis initially enters

through the intestinal epithelium

(3.18), the infection

may require an extended incubation in the mesenteric lymph
nodes before proliferating in the intestinal tract.
Failure to examine the mesenteric lymph nodes may have
prevented the detection of oral infections of mice in
previous studies (3.14).
This study indicates that certain genetically
susceptible strains of mice may serve as useful models in
studying the entry, immunology, and pathogenesis of
paratuberculosis.

Granulomatous lesions containing acid-

fast bacteria, similar to those of the natural disease of
ruminants, developed in mice following an oral infection
with Mycobacterium paratuberculosis.

Although it is

possible that these infections may have been self-limiting,
this seems unlikely since the severity of the lesions
increased with the duration of the experiment.

In

addition, more acid-fast bacteria were detected in the
lesions of mice infected for

11

months, compared to those

infected for shorter time periods, which suggested that the
organisms were viable and proliferating.

Had the

experimental interval been extended, the infection may have
been demonstrated in the intestines, as occurs in the
natural disease of ruminants.
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CHAPTER 4. COMPARISON OF NON-SPECIFIC MACROPHAGE
ACTIVATION BETWEEN C57BL/6 AND C3H/He MICE INFECTED
WITH MYCOBACTERIUM PARATUBERCULOSIS USING A
LISTERIA SP. CHALLENGE ASSAY
Introduction
Paratuberculosis (Johne's disease)

is a chronic,

granulomatous, intestinal disease of ruminants caused by
the acid-fast bacterium Mycobacterium paratuberculosis
(4.1-3).

Clinically, the disease is characterized by

progressive weight loss and intractable diarrhea (4.1-3).
Ruminants are infected at a young age, but several months
to years may elapse before clinical signs occur (4.2).

The

disease occurs throughout the world and is particularly
prevalent in domestic livestock (4.2).

Estimates of the

prevalence of paratuberculosis in the United States range
from 3-17% in culled dairy cattle (4.4).
The apparent lack of a suitable laboratory animal
model in which to study paratuberculosis previously
hampered research into the immunology of the disease.
Currently, little is known about the immune response to
infection with M. paratuberculosis. compared to other
mycobacterial infections such as tuberculosis and leprosy.
Recently, however, mice having the susceptible allele of
the Beg gene (Bcgs) have been shown to be susceptible to M.
paratuberculosis infection (4.5, chapters 2 and 3).
Susceptible mice develop progressive, granulomatous lesions
resembling those of the natural infection in ruminants, and
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may be used as a model to study the immunology and
pathogenesis of paratuberculosis (chapters 2 and 3).
The immunologic effects of Mycobacterium
paratuberculosis infection in mice have not been thoroughly
examined.

It has been shown that the DTH response against

sheep erythrocytes injected into the footpads of mice is
suppressed following an intraperitoneal (i.p.) injection of
non-viable M. paratuberculosis (4.6).

This suggests that

some degree of T cell-mediated immunosuppression is present
in the skin.

However, DTH responses are independent of CMI

responses, and often one may be present without the other
(4.7).

Thus, measurement of the DTH response may not be an

adequate measure of the protective CMI response in an
infected host.
The Listeria sp. challenge assay may be a more
accurate measurement of the level of the host CMI response
to infection (4.8-9).

The ability of a host to kill the

facultative intracellular parasite Listeria monocytogenes.
is known to reflect the level of activation of the host
mononuclear phagocytic (macrophage) compartment (4.8-10).
Macrophage activation is induced by a wide variety of
pathogens, and the measurement of the host response against
listeria may therefore be used to quantitate this non
specific resistance induced by entirely unrelated organisms
(4.9).

The listeria challenge assay has been widely used
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as a sensitive, in vivo measure of non-specific macrophage
activation (4.8-10).
To determine whether infection with Mycobacterium
paratuberculosis results in the activation or suppression
of macrophages, and to determine whether there are
detectable differences in the magnitude or timing of
macrophage activation between a mycobacterial resistant
versus susceptible strain of mouse, a listeria challenge
assay was employed.

Two strains of mice, differing in

their mycobacterial susceptibility, were inoculated with
Mycobacterium paratuberculosis and tested at various
postinoculation (pi) intervals.

Infected mice were then

assayed for their ability to kill listeria in vivo.
Materials and Methods
Mice
Both the C3H/HeN and C57BL/6N mice used in this study
were originally obtained from Harlan Sprague Dawley, Inc.,
Indianapolis, IN, and bred at the AAALAC accredited,
Louisiana State University, Division of Laboratory Animal
Medicine Vivarium.

Mice were housed in polypropylene

rodent boxes ("shoebox" cages) with stainless-steel wire
tops, on heat-treated, aspen-chip bedding (Sani-Chips, P.J.
Murphy Forest Products Corp., Montville NJ ) .

Animals were

fed Purina Rodent Chow 5001 (Purina Mills, Inc., St. Louis,
MO) and water ad libitum, and maintained on a 12/12-hour
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light/dark cycle.

All mice used in the study were infected

at 4-6 weeks of age.
Microrgani sms
Mycobacterium paratuberculosis ATCC strain 19698 was
obtained from the USDA-ARS, National Animal Disease Center
(NADC) Ames, Iowa and grown in Middlebrook 7H9 broth
supplemented with Middlebrook OADC enrichment media (DIFCO
labs, Detroit MI), 0.2% glycerol, and 2 mg/liter Mycobactin
J (Allied Laboratories, Glenwood springs, C O).

Broth

cultures were incubated at 37°C for 3-5 months and bacteria
were harvested by centrifugation (2000g), washed 3X in
phosphate-buffered saline (PBS), sonicated for 10 seconds
at 4 0W (Heat Systems-Ultrasonics Inc., Plainview, N.Y.) to
reduce clumping, and adjusted to 3 X 109 M.
paratuberculosis per dose as determined by a McFarlands
nephelometer standard.

The number of viable bacteria per

inoculum was later verified by plating serial dilutions on
Middlebrook 7H10 agar supplemented with OADC and Mycobactin
J.

Mice were inoculated by the intraperitoneal route with

1 X 109 bacteria suspended in 0.3ml sterile PBS.
A culture of Listeria monocytogenes was obtained from
Dr. James Krahenbuhl of the Hansens Disease Center, Baton
Rouge, LA.

(11) .

To increase the virulence, organisms were

passaged through Balb/C mice by intravenous inoculation and
recovery from the spleens 3 days later.

Virulent isolates

were then cultured in tryptic soy broth (TSB) for 18 hrs at
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37°C.

Cultures were centrifuged for 15 min at 1600 g and

resuspended in TSB containing 20% glycerol.

Aliquots of

the concentrated inoculum were stored frozen at -80°C.
Frozen aliquots were thawed and diluted with sterile PBS to
prepare individual inoculation doses containing 5 X 10s
bacteria suspended in 0.2 mis PBS.

Bacterial counts of the

inoculum were confirmed by plating serial dilutions on
tryptic soy agar and counting colony forming units after 24
hours of incubation at 37° in a humidified incubator.
Listeria Challenge Assay
Both resistant (C3H/He) and susceptible (C57BL/6) mice
were infected i.p. with 1 X 109 viable Mycobacterium
paratuberculosis bacilli.

The infections were timed so

that the listeria assay could be simultaneously performed
on groups of mice that had been infected with M.
paratuberculosis at postinoculation intervals of 4,
15, 22, 30, and 36 days.

8

, 10,

Control mice were inoculated i.p.

with 0.3 ml of sterile PBS 5 days before the start of the
assay.
mice.

Each postinoculation group consisted of at least

8

Only one strain of mice was used in some

postinoculation intervals.
Both mycobacterial infected and control mice were then
inoculated intravenously with 2 X 1 0s viable Listeria sp.
via tail vein injection.

After 24 hours, half of the mice

(n>4) were killed by cervical dislocation and spleens were
aseptically removed and stored in ice cold PBS.

Spleens

were homogenized in 10 mis PBS using pestle-type tissue
homogenizers (Thomas Scientific, Swedesboro, NJ) and serial
dilutions were plated on tryptic soy agar (TSA) petri
dishes.

Plates were incubated for 24 hours at 37° in a

humidified incubator and colony forming units (CFU) of
listeria were then determined using a colony counter
(Brunswick Scientific, New Jersey).

The remainder of the

mice were killed 48 hours after the listeria infection and
CFU of listeria were determined from the spleens of these
mice in the same manner.

The 24 hour listeria assay was

repeated, this time with fewer groups of mice infected at
intervals of 5, 10, 15, and 30 days.
Results
The growth of listeria in the spleens of control and
mycobacteria-infected mice is shown in figures 4.1-4.3.
Both C57BL/6 and C3H/Hen mice demonstrated markedly
increased listeria killing ability following an
intraperitoneal infection with Mycobacterium
paratuberculosis.

Although enhanced listeria killing was

evident by 5 days after the mycobacterial infection, peak
killing ability seemed to occur within ten days after the
infection.

Significant (P<0.05), logarithmic decreases in

the number of listeria CFU isolated from the spleens were
detected in all mice that had been inoculated

8

or more

days prior with M. paratuberculosis (Appendix B ) .

Although

the results of experiment 1 suggested that C3H/He mice may
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Figure 4.1. Experiment no.l; 24 hr. growth of listeria in
the spleens of mice infected at varying pi intervals with
Mycobacterium paratuberculosis. Each point represents the
mean CFU of at least 4 mice 24 hrs after listeria
infection. Inoculum = 2 X 105 listeria given i.v.
Error
bars indicate the standard error of the mean.
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Figure 4.2.
Experiment no. 1; 48hr. growth of listeria in
the spleens of mice infected at varying postinoculation
(p.i.) intervals with Mycobacterium paratuberculosis. Each
point represents the mean CFU of at least 4 mice 48 hrs
after listeria infection. Inoculum = 2 X 10s listeria given
i.v.
Error bars indicate the standard error of the mean.
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Figure 4.3.
Experiment no. 2; 24 hr. growth of listeria in
the spleens of mice infected at varying intervals with
Mycobacterium paratuberculosis. Each point represents the
mean CFU of at least 4 mice tested 24 hrs after listeria
infection. Inoculum = 2 X 10s listeria given i.v.
Error
bars indicate the standard error of the mean.
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be inherently more adept at listeria killing (Figs. 4.1,
4.2), experiment 2 showed that this was not the case (Fig.
4.3).

No statistically significant differences in the

magnitude or timing of macrophage activation were observed
between the two strains of mice.
Discussion
Resistance to mycobacterial infections is attributed
to effective cell-mediated immunity in which lymphocytemacrophage interactions predominate (4.12).

This

interaction usually leads to macrophage activation and
bacterial inhibition or clearance.

A correlation often

exists between the spectrum of lesions produced in response
to a particular pathogen and the host CMI status.

In

general, depressed CMI is present in patients with
lepromatous leprosy and atypical (MAI complex)
mycobacterial infections, while enhanced cell-mediated
immunity is a characteristic of tuberculoid leprosy and M.
tuberculosis infections (4.7,4.13-14).

The granulomatous

nature of the intestinal lesions produced by M.
paratuberculosis infections in cattle more closely resemble
those observed in lepromatous leprosy, suggesting that
depressed CMI responses may be present in paratuberculosis
as well (4.3).

Furthermore, in advanced stages of bovine

paratuberculosis, delayed-type hypersensitivity reactions
and lymphocyte transformation responses to M.
paratuberculosis antigens are often suppressed (4.2,4.15).

96
A decreased capacity to produce interleukin-2

(IL-2) has

also been observed in cattle chronically infected with M.
paratuberculosis (4.15).

This suggests that cattle

chronically infected with M. paratuberculosis have
defective or depressed CMI responses.
Since specific, inbred strains of mice have been shown
to be susceptible to Mycobacterium paratuberculosis
infections, it was hypothesized that differences in the
levels of macrophage activation might be detected between a
susceptible versus resistant strain of mice in response
infection with M. paratuberculosis.

The present study

attempted to detect a difference in the level of macrophage
activation between C3H/He (Bcgr) and C57BL/6 (Beg*) mice
using a listeria challenge assay.
Marked non-specific macrophage activation was
demonstrated in both Beg resistant and Beg susceptible
strains of mice by

8-10

days after infection with a large

i.p. dose of Mycobacterium paratuberculosis.

Although it

was previously shown that C57BL/6 mice are more susceptible
to paratuberculosis than C3H/He mice (chapters 2 and 3), no
innate differences in macrophage activation were detected
between the two strains using the listeria challenge assay.
Peak listeria killing ability for both mouse strains
occurred between 10 and 15 days (Figures 4.1-4.3).
Although all pathogenic mycobacteria are intracellular
pathogens with the capacity to grow inside phagocytic
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cells, the mechanism by which different mycobacterial
species escape host microbicidal functions varies from one
species to another (4.10,4.12).

Variation in the

resistance of mycobacteria to activated macrophages exists
even among closely related species (4.10).

Some

organisms, such as M. tuberculosis are sensitive to the
presence of activated macrophages, while some members of
the Mycobacterium avium/intracellulare (MAI) complex are
unaffected by activated macrophages (such as M. avium and
M. kansasii) while still others (such as M. intracellulare)
may actually grow better in the presence of activated
macrophages (4.10).
This experiment demonstrates that in mice, macrophage
activation, rather than macrophage suppression, results as
a consequence of infection with a large dose of
Mycobacterium paratuberculosis.

Although markedly fewer

numbers of viable Mycobacterium paratuberculosis organisms
are isolated from the spleens of C3H/He mice compared to
C57BL/6 mice within 10 days after infection (chapter 3),
equal levels of macrophage activation (as determined by
listeria killing ability) are present in both strains of
mice in response to the mycobacterial infection.

Although

this does not prove that there are no differences in the
level of macrophage activation between these two strains of
mice, these results indicate that the mechanisms used by
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macrophages to kill listeria are ineffective against
Mycobacterium paratuberculosis.
The mechanisms by which macrophages inhibit
intracellular pathogens vary widely, even amongst closely
related pathogens.

Immunity to Mycobacterium tuberculosis

for example, is mediated predominantly through the
activation of CD4+ T cells (4.16), whereas the relative
contribution of CD4+ T cells to protection against Listeria
sp. seems to be rather small (4.17-18).

Listeria sp.

killing is mediated predominantly through the action of
CD 8 + and

7

$ TCR+ T cells (4.18-20).

This is probably

mediated through the generation of different macrophageactivating cytokines from specific T cell subsets.
Stimulation of human and murine macrophages with certain
cytokines such as TNF and GM-CSF is associated with antimycobacterial activity (4.21).

In contrast, stimulation of

macrophages with IFN - 7 is associated with intracellular
killing of listeria (4.21).
and
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The mechanisms by which CD 8 +

T cells stimulate macrophages to kill listeria are

unknown, but probably involve the generation of reactive
nitrogen intermediates (RNI) within phagocytes (4.22).
generation of RNI has been shown to be associated with
listeria killing by murine (but not human) macrophages
(4.21).

Intracellular killing of Mycobacterium avium by

cytokine-activated human or murine macrophages, in

The
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contrast, is not dependent upon the generation of reactive
nitrogen intermediates (4.21).
It is still not known why some strains of mice (BcgT)
inhibit mycobacterial replication, while other strains
permit mycobacterial growth (Beg*) resulting in bacterial
persistence and disease.

Full elucidation of the

mechanisms by which the Beg gene confers resistance may
provide the key to controlling mycobacterial infections in
the future.
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CHAPTER 5. COMPARATIVE ANALYSIS OF THE T CELL KINETICS OF
C57BL/6 AND C3H/He MICE IN RESPONSE TO INFECTION
WITH MYCOBACTERIUM PARATUBERCULOSIS
Introduction
Paratuberculosis (Johne's disease) is a chronic,
granulomatous, intestinal disease of ruminants caused by
the acid-fast bacterium Mycobacterium paratuberculosis
(5.1-3).

Clinically, the disease is characterized by

progressive weight loss and intractable diarrhea (5.1-3).
Ruminants are infected at a young age, but several months
to years may elapse before clinical signs occur (5.2).

The

disease occurs throughout the world and is particularly
prevalent in domestic livestock (5.2).

Estimates of the

prevalence of paratuberculosis in the United States range
from 3-17% in culled dairy cattle (5.4).
Immunity to paratuberculosis and other mycobacterial
pathogens is believed to be cell-mediated, resulting from
the complex interactions of T lymphocytes and macrophages
(5.5-7).

Immunity to Mycobacterium tuberculosis infection

in mice, for example, is mediated primarily by a/3+ CD4+
CD 8 - T cells which activate macrophages, leading to
bacterial inhibition or clearance (5.6 ,5.8 ).
Another population of CD3+ cells, referred to as yS T
cells, have also been implicated in mycobacterial
infections.

These cells have been shown to increase in

response to tuberculosis and certain leprosy infections
(5.9-11).

Experimental infections of mice have shown that
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6 T cells increase in the draining lymph nodes in response

to infection with either M. bovis/BCG or M. tuberculosis
(5.8).

Despite this association, the role that
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T cells

play in mycobacterial infections is still unknown.
Resistance to mycobacteria and other intracellular
pathogens has been linked to a single gene referred to as
the Beg gene (5.12-13).

Although the product of this gene

is not known, mice with the resistant allele of this gene

{Beg') progressively eliminate mycobacteria, while those
with the susceptible allele (Bcgs) allow bacterial
proliferation and usually succumb to the disease (5.12-13).
Investigations into the mechanisms of this resistance
indicate that macrophages from susceptible mice are
inferior in killing mycobacteria when compared to resistant
mouse strains (5.14).

However, macrophages from Beg8 mice

can be activated to kill certain species of mycobacteria as
efficiently as those from Bcgr mice when stimulated by
cytokines (5.14).

This suggests that the mechanism of

resistance to mycobacteria may be at the T cell level
rather than the macrophage.
Although much research has been performed with
mycobacterial pathogens of humans, comparatively little is
known about the T cell kinetics of infection with
Mycobacterium paratuberculosis. To evaluate the kinetics of
the T cell responses of mice to infection with
Mycobacterium paratuberculosis. both C3H/He and C57BL/6
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mice were infected and tested at various postinoculation
(pi) intervals with an intraperitoneal dose of viable M.
paratuberculosis.

Lymphocytes were then harvested from the

peritoneal exudate cells (PEC), spleen, mesenteric lymph
nodes (MLN), intestinal epithelium, lamina propria, and
Peyer's patches from all mice.
Lymphocytes from all organs were analyzed for T cell
subsets by labelling with a variety of monoclonal
antibodies to detect changes in the proportions of T cell
subsets and cell activation markers in response to
infection.
To determine whether there were age-related
differences in the response to infection, the experiment
was repeated using aged mice (retired breeders). Only the
peritoneal exudate cells were examined in the repeat
experiment.
Materials and Methods
Microorganisms
Mycobacterium paratuberculosis ATCC strain 19698 was
obtained from the USDA-ARS, National Animal Disease Center
(NADC) Ames, Iowa and grown in Middlebrook 7H9 broth
supplemented with Middlebrook OADC enrichment media (DIFCO
labs, Detroit MI), 0.2% glycerol, and 2 mg/liter Mycobactin
J (Allied Laboratories, Glenwood springs, CO ) .

Broth

cultures were incubated at 37°C for 3-5 months and bacteria
were harvested by centrifugation (2000g), washed 3X in
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phosphate-buffered saline (PBS), sonicated for 10 seconds
at 40W (Heat-Systems Ultrasonics Inc., Plainview N.Y.) to
reduce clumping, and adjusted to 3 X 109 M.
paratuberculosis per dose as determined by McFarlands
standards.

The number of viable bacteria per inoculum was

later verified by plating serial dilutions on Middlebrook
7H10 agar supplemented with OADC and Mycobactin J. Mice
were inoculated by the intraperitoneal route with 1 X 109
bacteria suspended in 0.3ml PBS.
Mice
Both the C3H/HeN and C57BL/6N mice used in this study
were originally obtained from Harlan Sprague Dawley, Inc.,
Indianapolis, IN, and bred at the AAALAC accredited
Louisiana State University, Division of Laboratory Animal
Medicine Vivarium.

Mice were housed in polypropylene

rodent boxes ("shoebox" cages) with stainless-steel wire
tops, on heat-treated, aspen-chip bedding (Sani-Chips, P.J.
Murphy Forest Products Corp., Montville N J ) .

Animals were

fed Purina Rodent Chow 5001 (Purina Mills, Inc., St. Louis,
MO) and water ad libitum, and maintained on a 12/12-hour
light/dark cycle.

All mice used in the first study were

infected at 4-6 weeks of age.

In the second experiment,

retired breeders were used, with ages ranging from 12 to 30
months at the time of infection.
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Lymphocyte Isolation
Peritoneal exudate cells (PEC) were recovered from
mice by lavaging the peritoneal cavity with approx. 10 ml
of complete RPMI-1640 media containing 5% fetal bovine
serum (RPMI-5 , complete media).

Cells were washed twice by

centrifuging at 400g for 8 minutes with RPMI-5 and counted
by trypan blue exclusion using a hemacytometer.
Splenocytes were collected by aseptically removing the
spleen and placing them in sterile 15 ml centrifuge tubes
containing 3ml of ice-cold, calcium and magnesium free
phospho-buffered saline (PBS).

Spleens were then placed

upon sterile nylon mesh screens and minced with scissors.
Using a sterile lOcc disposable syringe plunger, the pieces
were gently pressed through the screen into a plastic petri
dish. Cells were washed through the screen with several
aliquots of PBS using a 5 ml pipette.

The splenocytes were

then transferred to 15 ml centrifuge tubes and washed IX
with PBS (400g, 8 min.).

Red blood cells were lysed by

suspending the cell pellet in 4 mis of prewarmed NH4C1
solution and incubated with shaking for 3 minutes in a 37°C
water bath. The cells were then washed with complete RPMI1640-5 and any large debris that quickly settled to the
bottom of the cell suspension was removed by pipetting.
Cells were suspended in RPMI-10 and placed on ice until
staining.
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Mesenteric lymph node cells were harvested by
carefully dissecting the nodes from the mesenteries and
removing as much fat as possible. The nodes were then
minced with razor blades and the fragments incubated in 15
ml centrifuge tubes with 3ml of RPMI-5 containing 0.05
mg/ml collagenase (SIGMA, type II). The fragments were then
pressed through nylon mesh screens with a plunger. Cells
were then washed 2X with PBS and resuspended in RPMI-10 and
placed on ice until staining.
Intestinal epithelial lymphocytes (IEL) and lamina
propria lymphocytes (LPL) were isolated from individual
mice using modifications of a previously described protocol
(5.15-16).

The small intestines were bluntly dissected and

removed from the abdomen and the mesenteries and blood
vessels were carefully removed by sharp dissection. The
lumens are flushed with 50 ml of cold PBS using a small
piece of tubing attached to a 60 cc syringe.

The Peyer's

patches were then identified and removed with the aid of a
dissecting microscope, and placed in 15 ml centrifuge tubes
containing 2 ml of RPMI-5 until used.

The intestines were

then opened longitudinally with small

scissors and cut

into 1 cm long pieces.

These were transferred to 125 ml

Erlenmeyer flasks and washed 3X by swirling in PBS and
discarding the supernatant fluid. The fragments were then
suspended in 25 ml of Hanks balanced salt solution (HBSS)
(Gibco) containing 104 M EDTA (SIGMA).

The intestines were
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then incubated at room temperature for 30 minute intervals,
while slowly stirring with a magnetic stir bar.

At the end

of each 3 0 minute interval, the cloudy supernatant fluid
(containing cells) was transferred to 50ml centrifuge tubes
and fresh HBSS/EDTA was added to the intestinal pieces.
This process was repeated at least three times or until the
supernatant fluid was no longer cloudy after incubation.
Histologic examination of some of the remaining intestinal
tissue fragments was performed to confirm that the
epithelium had been removed and the lamina propria was
still intact. The supernatant fluid was then passed through
60-ml syringe columns containing loosely packed glass wool
to remove dead cells and tissue debris.

To obtain the

lymphocytes, discontinuous density gradients were prepared
using Percoll (Sigma).

To prepare the gradients, an

isotonic preparation of Percoll was first made by mixing
one part of a 10X solution of PBS with nine parts Percoll.
This preparation was then diluted to 35% v/v and 60% v/v
with RPMI-5.

Gradients were prepared by underlayering 2 ml

of the 35% solution with 2 ml of 60% Percoll. The
epithelial cells were then suspended in 3-4 ml of RPMI-5
and layered onto the top of the gradient and centrifuged at
2000 rpm for 20 minutes (800g).

The interface between the

35% and 60% gradients which contained the lymphocytes was
then collected by pipetting.

Approximately 1-2 X 106
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cells/mouse were collected from these gradients.

The IELs

were suspended in RPMI-10 on ice until analyzed.
To collect lamina propria lymphocytes, the intestinal
pieces remaining from the IEL isolation procedures were
incubated in 25 ml of RPMI-5 containing 0.05 mg/ml
collagenase in a 37°C water bath with vigorous shaking for
three consecutive 30 minute intervals.

Following each

interval, the intestinal pieces were vigorously pipetted up
and down at least 20 times with a 5 ml pipette. At the end
of the third incubation, the pieces had usually dissociated
into small fragments.

To remove the tissue debris and dead

cells, the resulting suspension was passed over a 60cc
syringe column containing loosely packed glass wool.

To

enrich the lymphocyte population, the cell suspension was
centrifuged over a 3 5%/60% Percoll density gradient as
described for isolation of IELs.
Peyer's patches were pooled from each group of mice
and pressed through nylon mesh screens with a lOcc syringe
plunger. The cells were washed 2X with PBS and resuspended
in RPMI-10 until use.
Detection of T Cell Subsets
Cells from the above preparations were adjusted to 2 X
106 cells/ml and 50 ji1 aliquots were incubated with
appropriately diluted FITC or PE conjugated, anti-mouse
antibodies against CD3, a/3 TCR,

TCR, CD4, CD8a

(Pharmingen, San Diego, CA) on ice for 30 minutes.

For
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other experiments, identical batches of cells were labelled
with markers of cell activation (see chapter 6). Cells were
then washed with PBS and fixed in 1% paraformaldehyde
overnight.
Samples were analyzed on a FACScan flow cytometer
(Becton Dickinson, San Jose, CA) equipped with a 15mW aircooled 488 nm argon-ion laser.

The green fluorescence or

FITC staining was collected with a 530/30 nm band pass
filter.

Detection of phycoerythrin emission was filtered

through a 585/42 nm band pass filter.

Electronic

compensation was used among the fluorescence channels to
remove residual spectral overlap.

A minimum of 10,000

events were collected on samples taken from the various
tissues.

All samples were acquired in the list mode manner

on a Hewlett Packard 340 computer system (San Diego, CA)
and the data was analyzed using Lysys II software package
(Becton Dickinson, San Jose, CA).
A gated lymphocyte population was derived from a
bivariate histogram display of forward and side scatter,
thereby excluding macrophages and other nonlymphoid cell
types.

The gated lymphocytes were subsequently plotted on

a dot display illustrating log green fluorescence versus
log red fluorescence and immunofluorescence data for the Tcell populations were quantitated.

Gates were set at 20

and 100 for CD3, yS TCR, CD4 and CD8 analysis.
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Percentages of lymphocytes were determined rather than
the actual number for two reasons.

First, the actual

number of lymphocytes collected from the GALT would be
prone to error since the collection methods used result in
the collection of only a fraction of the total lymphocyte
population.

Experimental deviation between samples in

these tissues could significantly alter the results and
provide erroneous data.

Secondly, since T cells exert

their effects in a paracrine or autocrine manner, it was
believed that reporting the percentages of T cells in
relation to other cell populations are more important than
their actual number.
Statistical Analysis
Data was analyzed using a comparative analysis of
variance using Tukeys studentized range test.

For

comparisons between each group, least square means were
compared using a pairwise t test.

Groups of mice of

different postinoculation intervals were compared within
strains, and those of the same postinoculation intervals
were compared between strains.
Results
Peritoneal Cells of Infected Weanlings
Within 5 days after M. paratuberculosis infection,
marked increases in lymphocytes and macrophages were
detected in the peritoneal cavity (Fig. 5.1).

Peritoneal

lymphocyte populations continued to increase throughout the
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study.

Dual staining of cells with anti-CD3 antibodies

revealed a steady, continual increase in the proportion of
CD3+ cells (T cells) in the first 30 days (Fig. 5.2).
Although higher levels of CD4+ cells were detected in both
control and infected C3H/He mice compared to the C57BL/6
strain, the proportion of CD4+ cells (expressed as a
percentage of the total CD3+ population) dropped in
response to infection in both strains of mice (Fig. 5.3).
The predominant cells responding to the initial
infection in the peritoneum were either CD8+ and/or yS T
cells (Figs. 5.4-5.6).

No CD8+,y<S+ (double-positive) cells

were observed in the peritoneum of any mice (Fig. 5.6).
Although increases in CD8+ and yS T cells were noted in
both strains, significantly higher levels of these cell
types responded to the infection in the C57BL/6 strain
whereas more CD4+ cells were present in the C3H/He mice
(Figs. 5.3-5.5).
Peritoneal Cells of Mice Infected as Adults
The T cell responses of aged mice (retired breeders)
were similar to those infected as weanlings (Addendix D)
Marked increases in CD3+ cells were detected by 3 days p.i.
The majority of responding cells were yS TCR+ T cells.
Five-fold increases in the numbers of yS T cells were
present in both mouse strains within 5 days after
infection.

Uninfected C3H/He mice had markedly higher

proportions of CD4+ T cells than C57BL/6 but the
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Figure 5.1. Dot plot of forward vs side scatter analysis
of the peritoneal cell response to Mycobacterium
paratuberculosis infection in C57BL/6 mice. A: Represents
the resident peritoneal cell population of an uninfected
control C3H/He mouse. B: Represents the peritoneal exudate
cell population of a C3H/He mouse 5 days after M- Paratb.
infection.
Note the abundant population of lymphocytes (L)
and larger, less granular macrophages (M).
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Figure 5.2.
Comparison of the peritoneal CD3+ T cell
response of C3H/He and C57BL/6 mice to an intraperitoneal
infection with 1 X 109 viable Mycobacterium
paratuberculosis bacilli. Note the steady increase in the
proportion of CD3+ cells in response to the infection over
time.
Error bars indicate the standard error of the mean.
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Figure 5.3.
Comparison of the response of CD4+ T cells in
the peritoneum of C57BL/6 and C3H/He mice to infection with
Mycobacterium oaratuberculosis♦ Higher proportions of CD4+
T cells are present in C3H/He mice both in uninfected
controls (day 0) and early in the infection.
Error bars
indicate the standard error of the mean.
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Figure 5.4.
Comparison of the response of CD8+ T cells in
the peritoneum of C57BL/6 and C3H/He mice to infection with
Mycobacterium paratuberculosis. Although marked increases
of CD8+ cells respond to the infection in both strains of
mice, higher proportions are present in C57BL/6 mice both
in uninfected controls (day 0) and early in the infection.
Error bars indicate the standard error of the mean.
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Comparison of the response of gamma/delta
(yS) T cells in the peritoneum of C57BL/6 and C3H/He mice
to infection with Mycobacterium oaratuberculosis. Marked
increases of yS T cells are present in infected mice of
both strains compared to controls.
Error bars indicate
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Figure 5.6. Dot plot of the peritoneal cell response of a
C3H/He mouse 30 days after an i.p. infection with
Mycobacterium paratuberculosis. A: Most of the responding
cells are both CD3+, 7 $+ T cells.
B: Dual staining with 7 S
and CD 8 + antibodies shows that the cells are not double
positive for these markers.
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proportions of these dropped in both strains in response to
infection.

Uninfected C57BL/6 mice had higher proportions

of CD 8 + cells but these also dropped in response to
infection.

No significant differences between the

responses of young and aged mice were detected.
Spleen Cells
In both control and infected mice, the proportions of
CD4+ cells were higher in resistant mice (C3H/Hen) while
CD 8 + cells were the predominant T cell in C57BL/6 mice
(Fig. 5.7-5. 8 ).

Nostriking changes in the

T cell subsets were

proportions of

detected in the spleens of either

strain in response to infection.

The total percentage of

CD3+ cells dropped in some animals after infection,
possible due to B cell infiltration or proliferation.
Intraepithelial Lymphocytes
In both murine strains, the vast majority of the IEL
population was CD3 + ,

7

<5+, CD 8 +.

Although

7

8 T cells were

present in many other organs, the IEL's were the only
compartment in which significant numbers of double positive
CD 8 +,

7

$ TCR+ cells were observed.

Changes in response to infection with M.
paratuberculosis infection were
mice, consisting of

observed in the C3H/He

significant increases in the number of

CD4+ cells within 15 days postinoculation.

No other

significant differences were observed amongst the IEL's of
either strain.
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Figure 5.7.
Comparison of the CD4+ T cell response in the
spleens of C3H/He and C57BL/6 mice in response to infection
with Mycobacterium paratuberculosis. Note the higher
percentage of CD4+ cells in the C3H/He strain.
Error bars
indicate the standard error of the mean.

121

Spleen CD8+ Cell Response
60

I

) C3H/He n ic e
V777X C57BU6 n ic e

I

50
+

o

§40
o
o'"

» 30
0)
o

|

20

O

10

-

I

C o n tro s

3d

5d

■>

xi

10d

15d

i

30d

5mo

Postinoculation interval (d=days, mo=months)

Figure 5.8.
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Lamina Propria Lymphocytes
The total proportion of CD3+ lymphocytes in the lamina
propria significantly dropped in the C3H/He strain after
infection, suggesting that a stronger B cell response may
have developed in this strain.

Significantly higher levels

of CD4+ cells were present in the lamina propria of C3H/He
mice compared to the C57BL/6 mice (Fig. 5.9).

In both

strains, the proportions of CD4+ cells initially dropped,
but then rebounded, and by 30 days both strains had higher
proportions of CD4+ LPL's than uninfected controls (Fig.
5.9).

The initial LPL cells responding to the infection

were CD8+ and/or yS T cells in both mouse strains.

Marked

increases in CD8+ cells were detected in both strains by 3
days postinoculation.
Peyers Patches
Since Peyer's patches were pooled in all groups, only
trends over time are reported rather than statistically
significant data.

However, changes in the Peyer's patches

were similar to those in other organs.

Higher percentages

of CD4+ cells were present in the C3H/He mice in response
to infection while C57BL/6 mice had higher proportions of
CD8+ and/or yS T cells (Appendix C ) .
Mesenteric Lymph Modes
Both strains of mice had a slight drop in the
proportion of T lymphocytes (CD3+ cells) in response to
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Figure 5.9.
Comparison of the CD4+ T cell response in the
lamina propria of C3H/He and C57BL/6 mice in response to
infection with Mycobacterium paratuberculosis. Note the
higher percentage of CD4+ T cells in the C3H/He strain.
Error bars indicate the standard error of the mean.
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infection.

The proportion of T cells was consistently

higher in C3H/He mice than C57BL/6 mice.

Markedly higher

proportions of CD4+ cells were present in the mesenteric
lymph nodes of control and infected C3H/He mice compared to
the C57BL/6 strain (Fig. 5.10).

The average percentage of

CD4+ mesenteric lymphocytes was approximately 70% in C3H/He
mice while those of C57BL/6 mice averaged between 35% to
49% (Fig. 5.10).

These percentages remained relatively

stable throughout the infection.

The percentages of yS T

cells were consistently higher in the C57BL/6 mice than in
the C3H/He mice (Fig. 5.11).

No other significant changes

were detected amongst the mesenteric lymph node lymphocyte
subsets in response to infection.
Discussion
Previous studies have demonstrated that mice with the
Beg resistant allele (Beg1) inhibit the replication of
mycobacteria and certain other intracellular pathogens,
while murine strains with the Beg susceptible allele (Beg*)
allow proliferation of the pathogens, often resulting in
disease or death (5.12,5.17).

The product of the Beg gene

is not known and the mechanisms underlying this selective
susceptibility to intracellular pathogens are not
understood.

Macrophages from both Beg* and Bcgr strains of

mice have been demonstrated to have the same capacity to
kill certain mycobacteria when they are activated by the
appropriate cytokine signals (5.14).

Macrophage activation
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Comparison of the CD4+ T cell response in the
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response to infection with Mycobacterium paratuberculosis.
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strain.
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Comparison of the 7 $ T cell response in the
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is dependent upon cytokines, predominantly secreted by
antigen-activated T cells (5.18-19).

Although cytotoxic T

cells may play a role in the resistance to mycobacterial
infections, macrophage activation through T cell-derived
cytokines is thought to be the major effector mechanism
involved in controlling mycobacterial infections (5.20).
Specific T cell subsets produce different arrays of
cytokines and CD4+ T cells have been classified into two
major subsets, referred to as Thl and T h2, based upon the
pattern of cytokines they secrete (5.21).
cells produce IL-2 and

7 -IFN,

The Thl-type

which (in addition to having

a variety of other immunologic effects) are particularly
important in the activation of T cells and macrophages.
Thus, CD4+ Thl-type T cells are important in the generation
of a cell-mediated response required for resistance to
mycobacterial infections (5.22). In contrast, Th2 cells
produce IL-4, IL-5, IL- 6 , and IL-10, which lead to the
generation of a non-protective humoral immune response and
down-regulation of the protective Thl response (5.21-21).
Other T cell subsets, including

7

5 T cells and CD 8 + T

cells have been implicated in the pathogenesis of
mycobacterial infections.

The significance of the role

that CD 8 + cells play in mycobacterial infections is
uncertain, but they may be important in the destruction of
infected cells and/or macrophage activation via the
generation of IFN - 7

(5.23-24).

The function of

7

6 T is
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also uncertain but marked increases in the number and/or
proportion of this T cell subset have been described in
several types of mycobacterial infections (5.8-11).
Since mycobacterial immunity is dependent upon the
generation of specific T cell subsets, a comparison of the
T cell subsets responding to mycobacterial infections in
resistant and susceptible animals may assist in
understanding why certain hosts are susceptible while
others are resistant.
Our experiments have demonstrated that Begr mice
(C3H/Hen) have significantly higher proportions of CD4+ T
cells in their lymphoid organs and compartments as compared
to a Beg* mouse strain (C57BL/6).

Resistance to M.

paratuberculosis may therefore be dependent upon the
elaboration of cytokines from this CD4+ subset, resulting
in optimum macrophage activation and mycobacterial killing.
A similar mechanism of resistance to M. tuberculosis has
previously been demonstrated (5.6).

Experimental

depletions of CD4+ cells in mice have also been shown to
result in the exacerbation of the severity of M. kansasii
infections (5.23).
Susceptible mice (C57BL/6) were shown to have higher
proportions of CD8+ and/or yS T cells than C3H/He mice.
Both mouse strains respond to an intraperitoneal infection
with M. paratuberculosis with marked increases in yS T
cells.

No differences in the proportions of yS T cells
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were detected in mice infected at different ages.
suggests that while

7

This

S T cells may play a role in the early

response to pathogens, they do not seem to be associated
with long term mycobacterial resistance.
proportion of

7

The higher

<S T cells in the susceptible strain suggests

that they may play a role in susceptibility to the
infection.
The innate differences between Beg resistant and
susceptible strains of mice could be directly related to
the higher percentages of the CD4+ T cell subset in
resistant strains.

Additional studies using multiple

strains of mice might reveal that all Bcgr strains have
proportionally higher numbers of CD4+ cells that promote
increased resistance to mycobacteria and other
intracellular pathogens.

It is also possible, however,

that the prominence of CD4+ cells in resistant mice could
be secondary to other effects of the Beg gene.

Innate

differences in macrophages or other immune cells between
susceptible and resistant mice could be present, resulting
in excess production or impairment of specific cytokines,
which in turn, could lead to differences
profiles in the two strains.

in the T cell

Furthermore, macrophages from

Bcgr mice have been shown to be better at antigen
presentation than their Beg’ counterparts (5.25).

Since

T

cells are activated by appropriately presented antigens on
the surface of macrophages, a defect in antigen

presentation also could result in either a lack or surplus
of certain T cell subsets in susceptible mice.

Clearly

additional studies are needed to determine the mechanisms
responsible for the resistance to mycobacterial infections.

131
Literature Cited
5.1. Merkal, R.S. 1984. Paratuberculosis. In The
Mycobacteria: A sourcebook, G.P. Kubica and L.G. Wayne, Ed.
1984, Marcel Dekker Inc., New York, N.Y. pp. 1237-1249.
5.2.
Chiodini, R.J., H.J. Van Kruiningen and R.S. Merkal.
1984. Ruminant paratuberculosis (Johne's disease): the
current status and future prospects. Cornell Vet.
74:218-262.
5.3. Kreeger, J.M. 1991. Ruminant paratuberculosis-a
century of progress and frustration. J. Vet. Diag. Invest.
3:373-383.
5.4.
Chiodini, R.J. and C.D. Buergelt. 1993.
Susceptibility of Balb/c, C57/B6 and C57/B10 mice to
infection with Mycobacterium paratuberculosis. J . Comp.
Pathol. 109:309-319.
5.5. Rastogi, N. and H.L. David. 1988. Mechanisms of
pathogenicity in mycobacteria. Biochimie. 70:1101-1120.
5.6. Orme, I.M., E.S. Miller, A.D. Roberts, S.K. Furney,
J.P. Griffin, K.M. Dobos, D. Chi, B. Rivoire and P.J.
Brennan. 1992. T lymphocytes mediating protection and
cellular cytolysis during the course of Mycobacterium
tuberculosis infection. J. Immunol. 148:189-196.
5.7.
Piessens, W.F. 1989. Introduction to the immunology
of tuberculosis. Rev. Infect. Dis. 11:S436-S442.
5.8.
Griffin, J.P., K.V. Harshan, W.K. Born and I.M. Orme.
1991. Kinetics of accumulation of yS receptor-bearing T
lymphocytes in mice infected with live Mycobacteria.
Infect. Immun. 59:4263-4265.
5.9. Janis, E.M., K. S.H.E., R.H. Schwartz and D.M.
Pardoll. 1989. Activation of yS T cells in the primary
immune response to Mycobacterium tuberculosis. Science
244:713-716.
5.10. Augustin, A., R.T. Kubo and G.K. Sim. 1989. Resident
pulmonary lymphocytes expressing the yS T cell receptor.
Nature 340:239-241.
5.11. Modlin, R.L., C. Pirmez, F.M. Hofman, V. Torigan, K.
Uyemura, T.H. Rea, B.R. Bloom and M.B. Brenner. 1989.
Lymphocytes bearing antigen specific yS T cell receptors
accumulate in human infectious disease lesions. Nature
339:544-548.

132
5.12. Forget, A., E. Skamene, P. Gros, A.-C. Miailhe and R.
Turcotte. 1981. Differences in response among inbred mouse
strains to infection with small doses of Mycobacterium
bovis BCG. Infect. Immun. 32:42-47.
5.13. Skamene, E. 1989. Genetic control of susceptibility
to mycobacterial infections. Rev. Infect. Dis.
11:S394-S399.
5.14. Denis, M . , A. Forget, M. Pelletier, F. Gervais and E.
Skamene. 1990. Killing of Mycobacterium smeomatis by
macrophages from genetically susceptible and resistant
mice. J. Leuk. Biol. 47:25-30.
5.15. Davies, M.D.J. and D.M.V. Parrott. 1981. Preparation
and purification of lymphocytes from the epithelium and
lamina propria of murine small intestine. Gut 22:481.
5.16. Taguchi, T . , J.R. McGhee, R.L. Coffman, K.W. Beagley,
J.H. Eldridge, K. Takatsu and H. Kiyono. 1990. Analysis of
Thl and Th2 cells in murine gut-associated tissues. J.
Immunol. 145:68-77.
5.17. Skamene, E., G. Philippe, A. Forget, P.A.L.
Kongshavn, C. St. Charles and B.A. Taylor. 1982. Genetic
regulation of resistance to intracellular pathogens. Nature
297:506-509.
5.18. Krahenbuhl, J.L., L. Rosenberg and J. Remington.
1973. The effects of anti-thymocyte serum on in vitro
activation of macrophages. J . Immunol. 111:992-995.
5.19. Nathan, C.F., H.W. Murray, M.E. Wiebe and B.Y. Rubin.
1983. Identification of interferon gamma as the lymphokine
that activates human macrophage oxidative metabolism and
anti-microbial activity. J . Exp. Med. 158:670-674.
5.20. Appelberg, R . , R. Soares, P. Ferreira and M.T. Silva.
1989. Induction of non-specific immunosuppression in mice
by mycobacterial infections and its relationship to
macrophage activation. Scand. J. Immunol. 30:165-174.
5.21. Mosmann, T.R. and R.L. Coffman. 1989. TH1 and TH2
cells; different patterns of lymphokine secretion lead to
different functional properties. Ann. Rev. Immunol.
7:145-173.
5.22. Orme, I.M., A.D. Roberts, J.P. Griffin and J.S.
Abrams. 1993. Cytokine secretion by CD4+ T lymphocytes
acquired in response to Mycobacterium tuberculosis
infection. J. Immunol. 151:518-525.

133
5.23. Flory, C.M., R.D. Hubbard and F.M. Collins. 1992.
Effects of in vivo T lymphocyte depletion on mycobacterial
infections in mice. J. Leuk. Biol. 51:225-229.
5.24. Kaufmann, S.H.E. 1991. Role of T-cell subsets in
bacterial infections. Curr. Opin. Immunol. 3:465-470.
5.25. Denis, M . , E. Bushman, A. Forget, M. Pelletier and E.
Skamene. 1988. Pleiotropic effects of the Beg gene: antigen
presentation in genetically susceptible and resistant
strains of mice. J. Immunol. 140:2395.

CHAPTER 6 . COMPARATIVE ANALYSIS OF CD25 and CD44
EXPRESSION IN C57BL/6 AND C3H/He MICE INFECTED
WITH MYCOBACTERIUM PARATUBERCULOSIS
Introduction
Mycobacterial immunity is dependent upon a strong
cell-mediated immune response mediated by macrophages,
which are in turn dependent upon helper T cell signals for
proper activation (6.1-2).

Humoral immunity does not seem

to play a role in mycobacterial immunity, and may even be
detrimental to the host in some instances (6.3-5).
Infection of mice with Mvcobacterium paratuberculosis
results in distinct changes in the proportions of T cell
subsets in many lymphoid organs (chapter 5).

Resistant

mice have higher proportions of CD4+ T cells, both in
uninfected controls and in response to the infection,
whereas susceptible strains (C57BL/6) mice have higher
proportions of CD 8 + and

7

S T cells (chapter 5).

It was

thus demonstrated that resistance to M. paratuberculosis is
associated with increased proportions of CD4+ T cells
("helper T cells") , and CD 8 + and/or

7

S T cells are more

likely associated with bacterial susceptibility.
Specific T cell subsets produce different arrays of
cytokines (6 .6 ).

CD4+ T cells have been classified into

two major subsets, referred to as Thl and Th2, based upon
the pattern of cytokines they secrete (6 .6 ).
produce IL-2 and

7 -IFN,

Thl cells

which (in addition to having a

variety of other immunologic effects) are particularly
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important in the activation of T cells and macrophages.
Thus, Thl-type T cells are important in the generation of a
cell-mediated response required for resistance to
mycobacterial infections (6 .5,6 .7).

In contrast, Th2 cells

produce IL-4, IL-5, IL- 6 , and IL-10, which lead to the
generation of a humoral immune response and down-regulation
of the protective Thl response (6 .6 ,6 .7).

Although overlap

exists between the two types, the predominant CD4+ T cell
response to an infectious agent may either be a Thl type,
resulting in maximum macrophage activation and a strong
cell-mediated immune response, or it may be predominantly a
Th2 type, resulting more of a humoral immune response and
inhibition of the Thl type response (6 .4,6 .6 ).
The mechanisms leading to the predominance of one Thtype over the other are unknown, but a number of general
factors have been found to lead the response toward one or
the other.

Some factors that are known to favor the

generation of a Thl

(protective) response include the

presence of IL-2, IFN- 7 , activated CD 8 + cells, low antigen
doses, intracellular pathogens, larger (phagocytosed)
antigens, and the utilization of macrophages as the
predominant antigen-presenting cell (6 .8 ).
potent stimulator of Thl responses (6.9).

IL-12 also is a
Infections with

Listeria monocytogenes result in increased IL-12 production
by macrophages, which may be a key component of the host
resistance to intracellular pathogens (6.9).

Factors that
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generate a Th2 response include the presence of IL-4, IL10, IL-1, a lack of CD 8 + cells, high antigen doses, smaller
(pinocytosed) antigens, and the predominant use of B cells
as antigen presenting cells (6 .8 ).

IL-10 inhibits the

production of Thl cytokines in vitro and probably
suppresses Thl responses in vivo as well (6.9).
In an attempt to answer whether there were detectable
differences in levels of T cell activation and generation
of protective Thl responses between mycobacteriasusceptible and resistant strains of mice, lymphocytes were
harvested from a variety of lymphoid tissues and labelled
with monoclonal antibodies against CD4, CD25 and CD44
molecules.

Dual staining of cells with CD4 and the

activation markers was employed to determine whether CD4+ T
cells were activated.
In addition, assays for the production of IL-2 and IL4 were performed on supernatents of splenocytes and
peritoneal cells infected with Mycobacterium
paratuberculosis in vitro.

Cells from both C3H/He and

C57BL/6 mice were tested to determine whether there were
detectable differences in the production of these Thl and
Th2 type-specific cytokines in cells from Beg* and Bcgr mice
in response to the infection.

Cytokine assays were

performed using a CTLL-2 cell detection system and an MTT
colorimetric assay.
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The generation of a Thl response in response to an
infection should result in the production of increased IL2.

The expression of the IL-2 receptor (CD25) is highly

inducible in T cells by activation of the T cell antigen
receptors (6.10).

Thus, the activation of CD4+ T cells

(and other T cells) should be detectable as an increase in
the percentage of cells expressing CD25.
Expression of the cell membrane marker CD44 (Pgp-1)
was also analyzed in response to infection.

This marker is

expressed on several types of leukocytes, and has been
shown to be important in the recognition and/or adhesion of
activated T cells to certain endothelial receptors
important in transendothelial migration (6.11).

Although

CD44 supports binding of lymphocytes to high endothelial
venules, its functions in T cell homing are still unclear
(6.12).

The expression of CD44 has been reported to

increase in response to infection with some bacterial
pathogens (6 .1 2 ) and has also been utilized as a means to
identify memory T and B cells (6.13).

Cell membrane

expression of CD44 should therefore be increased if the
responding lymphocytes were activated in response to
infection with Mycobacterium paratuberculosis.
Materials and Methods
Microorganisms
Mycobacterium paratuberculosis ATCC strain 19698 was
obtained from the USDA-ARS, National Animal Disease Center

(NADC) Ames, Iowa and grown in Middlebrook 7H9 broth
supplemented with Middlebrook OADC enrichment media (DIFCO
labs, Detroit MI), 0.2% glycerol, and 2 mg/liter Mycobactin
J (Allied Laboratories, Glenwood springs, CO).

Broth

cultures were incubated at 37°C for 3-5 months and bacteria
were harvested by centrifugation (2000g), washed 3X in
phospho-buffered saline (PBS), sonicated for 10 seconds at
40W (Heat-Systems Ultrasonics Inc., Plainview N.Y.) to
reduce clumping, and adjusted to 3 X 109 M.
paratuberculosis per dose as determined by McFarlands
standards.

The number of viable bacteria per inoculum was

later verified by plating serial dilutions on Middlebrook
7H10 agar supplemented with OADC and Mycobactin J. Mice
were inoculated by the intraperitoneal route with 1 X 109
bacteria suspended in 0.3ml PBS.
Mice
Both the C3H/HeN and C57BL/6N mice used in this study
were originally obtained from Harlan Sprague Dawley, Inc.,
Indianapolis, IN, and bred at the Louisiana State
University, Division of Laboratory Animal Medicine
Vivarium.

Mice were housed in polypropylene rodent boxes

("shoebox" cages) with stainless-steel wire tops, on heattreated, aspen-chip bedding (Sani-Chips, P.J. Murphy Forest
Products Corp., Montville N J).

Animals were fed Purina

Rodent Chow 5001 (Purina Mills, Inc., St. Louis, MO) and
water ad libitum, and maintained on a

1 2 / 1 2 -hour

light/dark
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cycle.

With the exception of the second peritoneal cell

experiment which utilized retired breeders, all mice were
infected at 4-6 weeks of age.
Lymphocyte Isolation for Plow Cytometric Analysis
Peritoneal exudate cells (PEC) were recovered from
mice by lavaging the peritoneal cavity with approx.

10

ml

of complete RPMI-1640 media containing 5% fetal bovine
serum (RPMI-5, complete media).
centrifuging at 400g for

8

Cells were washed twice by

minutes with RPMI-5 and counted

by trypan blue exclusion using a hemacytometer.
Splenocytes were collected by aseptically removing the
spleen and placing them in sterile 15 ml centrifuge tubes
containing 3ml of ice-cold, calcium and magnesium free
phospho-buffered saline (PBS).

Spleens were then placed

upon sterile nylon mesh screens and minced with scissors.
Using a sterile lOcc disposable syringe plunger, the pieces
were gently pressed through the screen into a plastic petri
dish. Cells were washed through the screen with several
aliquots of PBS using a 5 ml pipette.

The splenocytes were

then transferred to 15 ml centrifuge tubes and washed IX
with PBS (400g,

8

min.).

Red blood cells were lysed by

suspending the cell pellet in 4 mis of prewarmed NH 4 C1
solution and incubated with shaking for 3 minutes in a 37°C
water bath. The cells were then washed with complete RPMI1640-5 and any large debris that quickly settled to the
bottom of the cell suspension was removed by pipetting.
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Cells were suspended in RPMI-10 and placed on ice until
staining.
Mesenteric lymph node cells were harvested by
carefully dissecting the nodes from the mesenteries and
removing as much fat as possible. The nodes were then
minces with razor blades and the fragments incubated in 15
ml centrifuge tubes with 3ml of RPMI-5 containing 0.05
mg/ml collagenase (SIGMA, type II). The fragments were then
pressed through nylon mesh screens with a plunger. Cells
were then washed 2X with PBS and resuspended in RPMI-10 and
placed on ice until staining.
Intestinal epithelial lymphocytes and lamina propria
lymphocytes were isolated from individual mice using
modifications of a previously described protocol (6.14-15).
The small intestines were bluntly dissected and removed
from the abdomen and the mesenteries and blood vessels were
carefully removed by sharp dissection. The lumens are
flushed with 50 ml of cold PBS using a small piece of
tubing attached to a 60 cc syringe.

The Peyer's patches

were then identified and removed with the aid of a
dissecting microscope, and placed in 15 ml centrifuge tubes
containing 2 ml of RPMI-5 until used.

The intestines were

then opened longitudinally with small

scissors and cut

into 1 cm long pieces.

These were transferred to 125 ml

Erlenmeyer flasks and washed 3X by swirling in PBS and
discarding the supernatant fluid. The fragments were then

suspended in 25 ml of Hanks balanced salt solution (HBSS)
(Gibco) containing 10^* M EDTA (Sigma) .

The intestines were

then incubated at room temperature for 30 minute intervals,
while slowly stirring with a magnetic stir bar.

At the end

of each 30 minute interval, the cloudy supernatant fluid
(containing cells) was transferred to 50ml centrifuge tubes
and fresh HBSS/EDTA was added to the intestinal pieces.
This process was repeated at least three times or until the
supernatant fluid was no longer cloudy after incubation.
Histologic examination of some of the remaining intestinal
tissue fragments was performed to confirm that the
epithelium had been removed and the lamina propria was
still intact. The supernatant fluid was then passed through
60-ml syringe columns containing loosely packed glass wool
to remove dead cells and tissue debris.

To obtain the

lymphocytes, discontinuous density gradients were prepared
using Percoll (Sigma).

To prepare the gradients, an

isotonic preparation of Percoll was first made by mixing
one part of a 10X solution of PBS with nine parts Percoll.
This preparation was then diluted to 35% v/v and 60% v/v
with RPMI-5.

Gradients were prepared by underlayering 2 ml

of the 3 5% solution with 2 ml of 60% Percoll. The
epithelial cells were then suspended in 3-4 ml of RPMI-5
and layered on the top of the gradient and centrifuged at
2000 rpm for 20 minutes (800g).

The interface between the

35% and 60% gradients which contained the lymphocytes was
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then collected with a pipette.

Approximately 1-2 X 106

cells/mouse were collected from these gradients.

The IELs

were suspended in RPMI-10 on ice until used.
To collect lamina propria lymphocytes, the intestinal
pieces remaining from the IEL isolation procedures were
incubated in 25 ml of RPMI-5 containing 0.05 mg/ml
collagenase in a 37°C water bath with vigorous shaking for
three consecutive 30 minute intervals.

Following each

interval, the intestinal pieces were vigorously pipetted up
and down at least 20 times with a 5 ml pipette.

At the end

of the third incubation, the pieces had usually dissociated
into small fragments.

To remove the tissue debris and dead

cells, the resulting suspension was passed over a 60cc
syringe column containing loosely packed glass wool.

To

enrich the lymphocyte population, the cell suspension was
centrifuged over a 35%/60% Percoll density gradient as
described for isolation of IELs.
Peyer's patches were pooled from each group of mice
and pressed through nylon mesh screens with a lOcc syringe
plunger. The cells were washed 2X with PBS and resuspended
in RPMI-10 until use.
Detection of T Cell Activation Markers
Cells from the above organs were adjusted to 2 X 106
cells/ml and 50 jul aliquots were incubated with
appropriately diluted, FITC or PE conjugated, anti-mouse
antibodies against CD4, CD25, and CD44 (Pharmingen, San
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Diego, CA) on ice for 30 minutes.

Cells were then washed

with PBS and fixed in 1% paraformaldehyde overnight.
Samples were analyzed on a FACScan flow cytometer
(Becton Dickinson, San Jose, CA) using standard techniques
as described in detail in chapter 5. Gates were set at 25
and 10 for analysis of CD44 and 16 and 35 for analysis of
CD25 for all samples analyzed.
Statistical Analysis
Flow cytometry data was analyzed using a comparative
analysis of variance using Tukeys studentized range test.
Each infected group was compared to controls using a
pairwise t test.
Cytokines and Reagents for In Vitro Studies
Recombinant murine IL-2 (rIL-2)(Genzyme, Cambridge,
MA) and recombinant murine IL-4 (rIL-4)(GIBCO BRL,
Gaithersburg, MD) were reconstituted in PBS containing 1%
FCS and stored at 4°C.

Aliquots containing 1670 U/ml (0.67

/ig/ml) of IL-2 and 1 X 105 U/ml (1.0 jug/ml) IL-4 were
prepared from the reconstituted solution immediately prior
to each experiment.
CTLL.2 Cell Line
The CTLL.2 cells were obtained from Dr. K. Smith of
Dartmouth University, and maintained in RPMI-1640 media
containing 1% sodium pyruvate, lOOmg/L ampicillin, lOOmg/L
streptomycin, 25mM L-Glutamine, HEPES buffer, 2-ME, and 10%
FCS.

For use in experiments, CTLL-2 cells were harvested 2
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days after splitting and washed 2X with PBS and resuspended
in complete RPMI containing 5% FCS.

Less FCS was used in

experiments to avoid protein precipitation reactions in the
MTT assay.
Preparation of Infected Cell Culture Supernatents
Splenocytes and peritoneal cells were isolated from
mice as described above.
additional 2X with PBS.

All cell samples were washed an
For experiment #1, peritoneal

cells were adjusted to 4 X 105 cells/ml and splenocytes
were adjusted to 5 X 106 cells/ml.

In the second

experiment, only peritoneal cells were used.

For each

experiment, 500/il aliquots of each cell suspension were
dispensed separately into 24-well, flat bottomed tissue
culture plates (Corning, N Y).

Half of all wells were

infected with 1 X 10s viable Mycobacterium paratuberculosis
suspended in 150/xl complete RPMI-10 (500:1 and 40:1
bacteria/cell for PEC's and Splenocytes respectively).

An

additional 150/jlI of complete RPMI-10 was added to control
wells.

All plates were then incubated for three days at

37°C with 5% C02 in a water-jacketed incubator.
Following incubation, the fluid from all wells were
aspirated and centrifuged at 3000rpm for

10

minutes to

remove all cells, bacteria, and debris.

These supernatents

were decanted for use in the cytokine assays.
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Cytokine Assays
The IL-2/IL-4 detection assays were performed using
CTLL.2 cells and the MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide] color detection method using
slight modifications of a previously described procedure
(6.16).

Supernatents from test samples were serially

diluted five-fold in 50/zl complete RPMI-5,

(beginning with

50% and ending with 0.01% final concentration)

in 96 well,

flat bottomed tissue culture plates (Costar, Cambridge,
MA) .
Cultures of CTLL.2 cells were harvested in active,
log-phase growth, washed twice with PBS to remove residual
IL-2, and resuspended in complete RPMI-5 at 1 X 106
cells/ml and 50/il of this cell suspension (50,000
cells/well) was added to each well of the 96-well plates.
Due to the high number of CTLL.2 cells required for the MTT
assay, only one repetition was performed in each test
sample.

For positive control wells, 20ng (5 X 103 U) of

IL-4 and 67 ng (17 U) of IL-2 were added to the first
wells, followed by wells containing serial, five-fold
dilutions.

To differentiate between IL-2 and IL-4

activity, duplicate wells containing test samples, CTLL.2
cells, and 0.01 mg anti-mouse IL-4 (Pharmingen, Sorrento,
CA) or 0.01 mg anti-murine IL-2 (Pharmingen, Sorrento CA)
were also prepared.

The plates were then incubated for 24

hrs at 37°C, 5% C02 in a humidified incubator.
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After 24 hrs of incubation, 10ju of 5mg/ml of filter
sterilized MTT/PBS solution was added to each well, and the
plates were incubated for an additional 24 hours.

After

this second incubation, 100/il of 0.04N HCL in isopropanol
was added to each well.

To completely lyse the cells and

to eliminate the formation of crystals, the solution was
vigorous pipetted 4-5 times.

The plates were read by an

automated microtiter plate reader (BioLinx 2.0, Dynatech
Labs) using a dual-wavelength filter set at 570nm and
63 0nm.
Results
Cell Surface Expression of CD2 5 and CD44
The results of the CD25 and CD44 expression are
tabulated in Appendix D.

Expression of CD25 was low in all

samples tested but significant differences between the two
mice were detected within the peritoneal exudate cells in
response to infection (Figure 6.1).

Expression of CD25

decreased following infection with Mycobacterium
paratuberculosis in the susceptible mice, while CD25
expression increased in the resistant strain (C3H/Hen) in
response to infection.

This phenomenon was present in both

mice that had been infected as weanlings and as adults.
Analysis of CD44 expression was difficult due to the
lack of clear distinctions between positive and negative
staining.

Although fixed gate settings were used to

analyze the data, the variation was high.

On the whole,

expression of CD44 initially decreased following infection,
probably due to an infiltration of naive cells lacking
homing markers.

Within 15 days postinoculation, the

percentages of CD44+ cells increased in the mesenteric
lymph nodes, peritoneal cavity, and the GALT in both
strains of mice.

Expression of CD44 was higher in the

mesenteric lymph nodes of C57BL/6 mice.

No significant

differences between the strains were detected in other
organs.

The number of CD4+/CD44+ (double positive) cells

also increased in the peritoneum, spleen, GALT, and
mesenteric lymph nodes following infection, suggesting that
some degree of activation was present in the responding
cells these tissues.
Cytokine Assays
No significant IL-2 or IL-4 production was detected in
any of the cell samples tested in the in vitro assays.

No

differences in CTLL.2 cell growth were detected between
infected and uninfected murine cells.

Wells containing the

highest amounts of the test-sample supernatents actually
had the lowest numbers of proliferating CTLL.2 cells
(Tables 6.1 and 6.2).

Control wells containing rIL-2 and

IL-4 did show significant CTLL.2 proliferation which was
measurable by the MTT colorimetric assay to the level of
0.6 Units/ml of IL-2 and 40 Units/ml of IL-4 (Table 6.1).
Wells containing CTLL.2 cells without exogenous cytokines
failed to proliferate.
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Figure 6.1.
Comparison of IL-2 receptor (CD25) expression
of the peritoneal cells of young C3H/He and C57BL/6 mice in
response to an intraperitoneal infection with Mycobacterium
paratuberculosis.

Table 6.1. Results of the CTLL-2 assay using MTT colorimetric assay for the detection of
IL-2 and IL-4 by murine cells infected with Mycobacterium paratuberculosis.

MOUSE
STRAIN

OPTICAL DENSITY (O.D.) READINGS
OF SAMPLE DILUTIONS:

CELL
SAMPLE
50.0%

C57BL/6
MICE

C3H/He
MICE

CONTROLS

a

10.0%

2.0%

0.5%

CYTOKINE CONTROLS
(O.D. READINGS)
0.01%

ANTI-IL4

ANTI-IL2

0.341

0.332

0.431

0.405

Spleen
(Infected)

0.410

0.426

0.433

0.456

ND

Spleen
(uninfected)

0.396

0.436

0.433

0.444

ND

PEC
(infected)

0.275

0.464

0.471

0.511

ND

0.346

0.321

PEC
(uninfected)

0.419

0.448

0.475

0.502

ND

0.399

0.259

Spleen
(infected)

0.399

0.413

0.443

0.476

ND

0.524

0.314

Spleen
(uninfected)

0.492

0.438

0.435

0.479

ND

0.533

0.155

PEC
(infected)

0.364

0.339

0.383

0.426

ND

0.329

0.301

PEC
(uninfected)

0.399

0.358

0.328

0.379

ND

0.370

0.264

IL-2 alone*

0.794

0.543

0.262

0.376

0.486

ND

ND

IL-4 aloneb

0.664

0.485

0.228

0.230

0.230

ND

ND

CTLL-2 only

0.267

0.230

0.257

0.229

0.229

ND

ND

C3H PEC only

0.036

0.036

0.039

0.041

0.030

ND

ND

Five-fold serial dilutions of IL-2 containing 17 units m
the second, etc.

the first well, 3.4 U in

Table 6.2. Results from the repeated assay for the detection of IL-2 and/or IL-4 from
cells infected for 3 days with Mvcobacterium paratuberculosis. Assay was performed using
CTLL-2 cells and an MTT colorimetric assay.

SAMPLE DILUTION (O.D.)
MOUSE
STRAIN

SAMPLE
PEC'S

50%

10%

INFECTED

0.341

0.380

0.414

0.290

0.269

CONTROL

0.330

0. 362

0.431

0.304

0.294

INFECTED

0.294

0.379

0.410

0.203

0.145

CONTROL

0.363

0.396

0.417

0.309

0.327

IL-2/CTLL CELLS ALONE

0.590

ND

ND

ND

ND

IL-4/CTLL CELLS ALONE

0.388

ND

ND

ND

ND

C57BL/6

C3H/HE

2

.0 %

ANTI IL2
ADDED

ANTI IL4
ADDED

Results are expressed as optical density using an MTT colorimetric assay to detect
proliferation of CTLL.2 cell.
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Discussion
Mice resistant to M. paratuberculosis infection
(C3H/He) have markedly higher proportions of CD4+ cells,
both initially and in response to infection as compared to
a susceptible (C57BL/6) strain (chapter 5).

Both mice

respond to an intraperitoneal infection with marked
increases in CD 8 + and y6 T cells (chapter 5).

This

indicates that specific T cell subsets are recruited to an
infection with Mycobacterium paratuberculosis. but says
little of their state of activation or functional
capabilities.
These results of this experiment show that CD44+
expression in most organs is initially decreased, probably
as a result of the recruitment of naive T cells to the
infection.

Within 15 to 30 days after infection, however,

increased numbers of CD44+ cells were detected in all
organs examined.

Dual-labelling and the use of two-color

flow cytometry revealed that the number of CD4+ cells co
expressing CD44 also increased in response to infection.
This suggests that the recruited cells are increasing their
expression of homing receptors and are therefore probably
in some state of activation.
Cattle chronically infected with Mycobacterium
paratuberculosis have a decreased capacity to produce IL-2
(6.17).

Activation and proliferation of T lymphocytes is

dependent upon the interaction of IL-2 with its cell
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membrane receptor (6.18).

A similar defect in IL-2

responsiveness is present in other mycobacterial infections
as well.

Cells from patients with atypical mycobacterial

(MAI) infections produce very low levels of IL-2 production
in response to PPD, but these cells may be stimulated to
produce normal levels of IL-2 when treated with Con A, PHA,
or PWM (6.18).

Although there is decreased IL-2

production, the expression and function of the IL-2
receptor in cells from patients with MAI infections is not
impaired (6.18).

Mycobacterium leprae and its components

have been shown to induce suppression of T cell
proliferation in vitro in cells from both leprosy patients
and uninfected controls (6.19).

Cells isolated from the

peripheral blood of BCG vaccinated patients have also been
shown to inhibit the proliferation of other cells to BCG
but not to other mitogens (6.20).

Suppressor cells might

therefore, act by inhibiting IL-2 production (6.18).
The results of this study demonstrate that detection
of IL-2 receptor (CD25) expression by flow cytometry is
decreased in a susceptible mouse strain (C57BL/6), whereas
in the resistant strain, IL-2Rc expression increased in
response to infection with Mycobacterium paratuberculosis.
This suggests that resistant mice may develop a protective,
Thl response, resulting in optimum macrophage activation
and mycobacterial killing.

Susceptible mice, on the other
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hand, fail to upregulate IL-2Rc expression and probably do
not develop a protective immune response.
Although further proof is needed, this suggests that
decreased IL-2Rc expression might be one of the factors
involved in susceptibility to paratuberculosis.

However,

detection of an actual change in the expression of a cell
surface receptor using monoclonal antibody techniques
requires ruling out the possibility that some of the
receptors are not simply masked by the presence of abundant
quantities of its ligand, in this case interleukin

2

.

Neither IL-2 or IL-4 was detected in cells infected with M.
paratuberculosis in vitro.

The failure to detect these

cytokines could be due to a number of factors, such as too
short of an incubation period, poor sensitivity of the
assays employed, or inherent differences in the response of
cells grown in vitro versus in vivo.
It is also plausible that the defect lies in the
expression of the IL-2 receptor and not the production of
IL-2 itself.

It has been demonstrated in leprosy, for

example, that the failure of T cells from lepromatous
leprosy patients to respond to M. leprae was due to a
defective IL-2 receptor expression mechanism (6.21).
If there is a bona fide decrease in the IL-2 receptor
expression of susceptible animals, this may be secondary to
a decreased production of IL-2.

Additional studies are

needed to test if the regulation of IL-2 or the expression

if the IL-2Rc are genuinely altered in mycobacterial
infections.

If IL-2 dysregulation is involved in the

pathogenesis of mycobacterial disease, then perhaps
modulation of the immune system through cytokine therapy
could be therapeutically beneficial.
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CHAPTER 7. CONCLUSIONS
Paratuberculosis is a chronic, insidious, intestinal
disease of ruminants that results in annual losses of
millions of dollars for the cattle industry (7.1).
Comparatively few cattle actually die from the disease, as
the vast majority of losses result from decreased
production and weight gains which are often subtle and go
undetected (7.1).
The lack of an accepted laboratory model for studying
paratuberculosis should no longer hamper research into
paratuberculosis.

The results presented here indicate that

C57BL/6 mice are a suitable model for studying the entry,
pathogenesis, and the immunology of ruminant
paratuberculosis.

As in the ruminant, susceptible mice

develop granulomatous lesions comprised of numerous
macrophages and multinucleated giant cells in the
mesenteric lymph nodes within 7 months postinoculation.
These lesions contain viable acid-fast bacilli, and the
disease is progressive, as demonstrated by the progression
of the lesions and bacterial culture counts.
Comparative studies of the mycobacterial counts from
chronically infected resistant and susceptible mice
demonstrated that the former are markedly more resistant to
Mycobacterium paratuberculosis♦

These data are compatible

with the dogma that resistance to mycobacterial infections
in mice is associated with the Beg gene.
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Comparative studies using susceptible and resistant
mice may help determine what factor(s) make one individual
susceptible to mycobacterial disease while another is
resistant.

Genetic mapping of cattle, in the hopes of

identifying a bovine equivalent of the Beg gene of mice,
might one day serve to eradicate paratuberculosis and
several other cattle diseases by selective breeding.
Both resistant and susceptible mice developed non
specific macrophage activation within

10

days after

infection with Mycobacterium paratuberculosis. suggesting
that the major T cell responses occur somewhere within this
time period.

No detectable differences were observed in

listeria killing ability between the two strains of mice.
This indicates that the mechanisms utilized by macrophages
to control Listeria sp. may be different than those
utilized to control mycobacteria.

The listeria challenge

assays were valuable in determining the peak timing of
macrophage activation following M. paratuberculosis
infection.

The T cell response could then be analyzed

during this time frame to determine what T cell subsets
were important in activating these macrophages.
Studies of the murine T cell response to infection
with M. paratuberculosis revealed that both control and
infected resistant mice have a significantly larger
complement of CD4+ cells as compared to the susceptible
mice.

Although only two strains of mice were employed in
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this study, this may prove to be a key factor in resistance
to mycobacterial diseases.

The increased proportion of

CD4+ cells might be directly attributed to the Beg gene,
possibly by directing the maturation of more CD4+ cells
through the production of cytokines.

Perhaps the key lies

in the production of IL-12, a recently discovered cytokine
that seems to direct the immune system towards the
protective Thl type response (7.2).
Analysis of CD 8 + and

7

S T cells demonstrated that

these cell types both responded in high proportions to the
mycobacterial infection in both resistant and susceptible
strains of mice.

The proportions of

75

T cells were

actually higher in several organs of the susceptible
strain, suggesting that if

7

S T cells do play a role in

mycobacterial infections, it may be a detrimental one.
Significant differences in the expression of the
interleukin - 2 receptor were also detected in the peritoneal
exudate cells responding to the infection.

Expression of

IL-2Rc by lymphocytes significantly increased in the
resistant strain of mice, but decreased in the susceptible
strain in response to infection with Mycobacterium
paratuberculosis.

This suggests that differences in IL-2

regulation or function are also present between
mycobacterial resistant and susceptible animals.

This has

been previously described in cattle infected with
Mycobacterium paratuberculosis (7.4,7.5).

Lymphocytes
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from chronically infected cattle have an impaired capacity
to produce IL-2 when stimulated by appropriate antigens
(7.4,7.5).
The results of these studies suggest that the major
difference between the susceptible and resistant strain is
the difference in the proportions of T cells subsets in the
lymphoid organs.

Helper T cells (CD4+) are associated with

a mycobacterial resistant strain while increased numbers of

y 6 T cells are associated with the susceptible strain.

The

increase in y S T cells may therefore be directly involved
in the pathogenesis or susceptibility to paratuberculosis.
Previous reports using peripheral blood lymphocytes of
cattle have suggested that yS T cells may actually be
involved in the destruction of autologous CD4+ cells (7.3).
According to this hypothesis, CD 8 + cells are reportedly
involved in down-regulating yS T cell cytotoxicity (7.3).
If this hypothesis is valid, the loss of CD4+ cells might
be responsible for the unchecked bacterial proliferation in
the latter stages of the disease (7.3).

The results

presented here, however, did not provide any evidence that
CD4+ cells were being destroyed.

Chronically infected mice

still had proportions of CD4+ T cells equal to or higher
than those of controls.
Other observations suggest that yS T cells may play a
role in the pathogenesis of paratuberculosis.

First, yS T

cells are numerous in the epithelial layers of the ruminant
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gastrointestinal tract (7.6).

Secondly, these cells have

demonstrated reactivity to products of different
mycobacterial species including M. leprae (7.7), M. bovis
(7.8), and M. tuberculosis (7.8-9).

Finally, the

prominence of yS T cells in the circulation of young
ruminants (7.6) coincides with the age of susceptibility of
cattle to infection with Mycobacterium paratuberculosis.
There are several possible mechanisms by which the yS
T cell could predispose the ruminant to developing
paratuberculosis.

One mechanism could be through the

induction of alterations in the bacillus-infected
macrophage.

Perhaps Mycobacterium paratuberculosis

organisms, once they are inside the cell, either stimulate
a cell-surface change or halt the production of stress
proteins that would otherwise trigger the yS T cell to
destroy the infected cell.
stimulation of the

7

A second hypothesis is that

$ T cells leads to the secretion of

certain cytokines that triggers the granulomatous lesions
without invoking the protective CD4+ cell response.

Others

have suggested that yS T cells may be responsible for
stimulating the formation of granulomatous lesions in
certain leprosy lesions (7.7).
A more plausible theory is that tolerance to the
invading bacillus is evoked through the yS T cell.
Histologic observations of age-related changes in the
ruminant ileal Peyer's patches have led to speculation that
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these patches may function as primary lymphoid organs in
young animals (7.10).
7

In addition, there is evidence that

S T cells develop and mature in the intestines rather than

the thymus (7.11).

Since young ruminants have markedly

increased numbers of yS T cells both in circulation and in
the intestines, perhaps an immune-tolerance phenomenon
occurs when large numbers of maturing yS T cells encounter
large numbers of Mycobacterium paratuberculosis organisms.
Distinction between self and non-self may fail to occur and
the susceptible animal may allow bacterial proliferation
without eliciting a protective immune response.
Future studies could be directed towards utilizing
this information in therapeutic trials.

Therapy directed

against the yS T cell population given to neonatal calves
during the age of susceptibility to the infection (under
three months of age) may be considered.

Although the

functions of yS T cells are still not known, if they are
somehow involved in down-regulating a protective immune
response, then perhaps elimination of these cells in
susceptible animals may prevent this immunosuppression.
Further studies in laboratory animals are needed before
this therapy can be employed.
Other potential therapies could be directed toward
stimulating a protective immune response.

Since resistance

to mycobacterial disease is dependent upon specific types
of CD4+ T cells, then modulation of these cell types or

their cytokines might be therapeutically useful.

The CD4+

cells responsible for stimulating protective cell-mediated
immunity are currently referred to as Thl (7.12).

It has

recently been shown that IL-12 can specifically promote the
development and activation of this Thl response (7.13).
Currently research is underway in other diseases to see if
IL-12 therapy can modify and direct the immune response
towards the protective Thl-type response (7.13).

If these

trials are successful, perhaps IL-12 therapy could benefit
cattle with paratuberculosis as well.
At the present time, understanding of the immunology
and pathogenesis of mycobacterial diseases is limited.
Currently, there is much work being done in these areas.
Hopefully, the secrets of the immune system and the
mycobacteria will eventually be revealed, enabling us to
understand, prevent, and/or treat these dreadful diseases
that have plagued both humans and domestic animals
throughout time.
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Table A.I. Mycobacterium paratuberculosis colony forming
units (CFU) isolated from the spleens of infected mice at
various postinoculation intervals.
C3H/He mice

C57BL/6 mice
Days"
(p.i.)

nb

M. para
CFU0

SEd

nb

M. para
CFU®

SEd

3

3

2.7X10 6

1.6X105

3

2.9X10 6

3.2X10 5

10

7

3.3X107

1.3X107

3

7.4X10 5

1.0X105

15

7

2.4X107

5.4X10 3

ND

---

---

21

4

9.2X10 6

9. 3X10S

ND

---

_ —

30

9

1.5X107

6.4X106

ND

---

---

36

4

2.2X10 6

9.2X105

ND

---

---

79

4

3.9X106

8.1X105

ND

---

---

85

3

9.4X10 6

3.3X106

ND

---

---

194

ND

---

---

8

2.0X10 4

5.4X10 3

219

ND

---

---

9

6.9X10 3

1.0X103

226

3

4.3X10 7

4.0X107

4

5.3X10 3

1.7X103

269

3

5.3X10 6

1.2X10 6

4

1.8X104

9.3X10 2

a
Number of days post-inoculation
(p.i.) with
Mycobacterium paratuberculosis.
b
Indicates the number of animals tested in each group,
c
Mean number of colony forming units of Mycobacterium
paratuberculosis per spleen,
d
Standard error of the mean.
ND
Not determined.
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Table B.l. Comparison of Listeria sp. colony forming units (CFU) obtained from the
spleens of mice inoculated with Mycobacterium paratuberculosis (experiment no. 1).
24 hour Listeria assay*
p. l. e
M.para
*

C3H/Hen mice
±SEe

cFtr1

C3H/Hen mice
±SE

CFU

±SE

5.9X106

2.9X106

4. lxlO7

1.7X107

1.4x10s

2.2X104

9.2x10s

3.7x10s

2. 4xl04

4 day

4. 6xl04

9.9x10s

ND

8 day

3.4xl03

8.8X102

1.3x10s

7.7X104

6. OxlO4

1.6X104

ND

ND

ND

1.1x10s

3. 0x10s

ND

C57BL/6 mice

CFU

1.7x10s

ND

ND

ND

3.9x10s

1.2x10s

4.6x10s

1.8X104

15 day

7.6x10s

1.9x10s

2.5X104

1.8X104

1.2x10s

3.4X104

4. lxlO4

1.9X104

22 day

6.3X104

2.9X104

8.4X104

2.9X104

8.6x10s

4.9x10s

1.2x10s

6.1x10s

30 day

1.3X104

3.6x10s

7. OxlO4

2.4X104

2.3x10s

4.4X104

1.2x10s

2.4x10s

3 6 day

5.7X104

1.3X104

1.2x10s

6.8X104

1.3X106

4.0x10s

1.1x10s

8.6x10s

ND

1.7x10s

5.3X104

5.0x10s

1.7x10s

ND

7. OxlO4

8.2x10s

ND

79 day

ND

85 day

d
e

C57BL/6 mice
. ... CFUd
±SEe

Control

10 day

a
b
c

48 hour Listeria assayb

ND

ND

ND

ND

1.9x10s
5.9x10s
________
Data obtained from mice 48 hours after i.v. inoculation with Listeria sp.
Postinoculation (p.i.) interval after infection with
Mvcobacterium paratuberculosis.
Colony forming units (CFU) of Listeria sp. per spleen,
Standard error of the mean of Listeria sp. CFU from the spleen.
1

"«

1

.

1

—'

11

T

.

Table B.2. Comparison of Listeria CFU from the spleen of mice infected with Mycobacterium
paratuberculosis. All counts were performed 24 hours after an i.v. infection with 4X105
viable Listeria sp. (experiment no. 2).

C3H/He mice
_b
n

CFU
Listeri
ac

SEd

Pe

nb

CFU
Listeri
ac

SEd

Pe

Control

5

1.3X107

3 .1X106

---

4

1.9X106

7.0X105

---

5 day

5

1.5X106

3.5X105

0.01

5

1.6X105

2.6X104

0.02

day

4

9 .8X104

3.4X104

<0 . 0 1

4

8.3X104

2.2X104

0.04

15 day

4

6 .1X104

1.4X104

<0 . 0 1

5

6.7X105

2.2X10 5

0.04

30 day

5

1.6X104

4.5X10 3

<0 . 0 1

4

1.3X105

2.9X104

0.04

P.I.
M.

para”

10

a
b
c
d
e

C57BL/6 mice

Postinoculation interval with Mycobacterium paratuberculosis. All mice
including controls were inoculated with Listeria sp. 24 prior,
Number of animals tested in each group.
Colony forming units (means) of Listeria isolated from thespleens,
Standard error of the mean.
P value indicating the significance of thedifference between
the CFU from the
infected groups and the uninfected control mice.
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Table C.l. Summary of the kinetics of the T cell response of the peritoneal exudate cells
of C57BL/6 and C3H/He mice infected with Mycobacterium paratuberculosis.
C3H/He mice
(resistant)

PI int.*

n

%CD3+b

%CD4+c

%CD 8 +C

%y 6 +c

controls

6

14.7 ± 1.7

72.2 ± 3.8

13.8 ± 2.5

14.8 ± 2.4

3 days

3

34.9 ± 3.4*

50.7 ± 4.2*

19.7 ± 5.3

33.6 ± 5.1*

5 days

3

54.5 ± 5.3*

73.1 ± 4.6

10.6

1.0

15.0 ± 4.4

days

3

70.2 ± 8.4*

35.6 ± 6.0*

25.5 ±10.3

34.3 ±17.4

15 days

3

53.8 ± 6.9*

34.8 ± 6.1*

10.7 ± 1.9

63.1 ±10.4*

30 days

3

67.0 ± 9.4*

48.5 ±15.2*

18.9 ± 3.3

30.3 ±18.2

5 months

3

39.5 ± 12.9*

26.5 ± 5.3*

7.3 ± 2.0

controls

6

24.5 ± 2.8

49.8 ± 2.4

16.5 ± 4.9

22.4 ± 3.2

3 days

3

59.2 ± 8.9*

36.6 ± 3.6*

32.4 ± 3.7

31.5 ± 5.7

5 days

3

43.7 ± 14.9

27.5 ± 7.6*

21.0 ± 3.6

62.7 ± 2.7*

days

3

62.0 ±

6

.6 *

29.5 ± 4.6*

37.4 ± 0.5

36.3 ± 1.9*

15 days

3

72.0 ±

6

.6 *

31.2 ± 4.2*

14.8 ± 4.8

65.8 ± 5.6*

30 days

3

77.8 ± 2.2*

51.0 ± 6.7

25.6 ± 4.8

24.9 ±

5 months

3

27.4 ±

40.3 +12.9*

19.2 ± 4.8

11.5 ± 1.1*

10

C57BL/6 mice
(susceptible)

10

a
b
c
*

6.9*

±

2.3 ± 1.9*

Postinoculation interval with Mycobacterium paratuberculosis.
Percentage of the total lymphocytes expressing CD3 ± standard error,
Expressed as a percentage of total CD3+ cells ± standard error.
Indicates a significant difference (P<0.05) from the uninfected controls.

8.6

Table C.2. Summary of the kinetics of the T cell response in the peritoneal exudate cells
of aged mice (of retired breeders) in response to infection with Mycobacterium
paratuberculosis.
C3H/He mice
(resistant)

PI int.*

n

%CD4+°

%CD 8 +C

controls

3

8.2 ± 0.3

82.9 ± 4.9

16.3 ± 2.0

5 days

3

32.1 ± 1.3*

34.1 ± 7.5*

12.5 ± 0.5

51.5 ±

days

3

51.1 ± 7.4*

39.3 ± 5.9*

17.4 ± 0.9

37.9 ± 7.0*

15 days

3

57.3 ± 5.4*

46.9 ± 2.0*

11.2 ± 1.5

42.3 ± 4.2*

30 days

3

42.2 ± 14.5*

49.8 ± 7.9*

25.4 ± 1.1*

23.5 ± 7.3

controls

3

25.6 ± 4.4

40.9 ± 5.6

45.7 ± 9.2

11.4 ± 5.6

5 days

3

60.1 ± 2.3*

20.5 ± 3.7*

12.6 ± 4.3*

52.7 ± 7.5*

days

3

68.7 ± 1.9*

24.0 ± 8.4

32.2 ± 8.2

43.8 ±
16.3*

15 days

3

68.4 ± 2.9*

34.4 ± 3.4

15.6 ± 2.9*

52.1 ± 4.2*

30 days

3

79.1 ± 3.0*

41.3 ± 7.3

21.1 ± 4.1

36.1 ±

10

C57BL/6 mice
(susceptible)

10

a
b
c
*

%CD3+b

%Y S+c
7.5 ± 2.8

Postinoculation interval with Mycobacterium tuberculosis,
Percentage of the total lymphocytes expressing CD3 ± standard error,
Expressed as a percentage of total CD3+ cells ± standard error.
Indicates a significant difference (P<0.05) from the uninfected controls.

6

6

.6 *

.8 *

Table C.3. Summary of the kinetics of the T cell response in the spleens of C57BL/6 and
C3H/He mice to infected with Mycobacterium paratuberculosis.
C3H/He mice
(resistant)

PI int.*

n

%CD3+b

%CD4+c

%CD 8 +c

controls

7

41.0 ± 3.1

71.1 ± 2.1

16.2 ±

3 days

3

31.0 ± 1.9

74.0 ± 2.8

15.4 ± 0.8

12.8 ± 1.4

5 days

3

28.8 ±

2.2

77.9 ± 3.5

9.0 ± 1.2

25.0 ± 0.6

days

3

41.0 ± 8.7

63.8 ± 0.5

28.2 ± 1.4*

9.1 ± 0.6

15 days

3

25.3 ± 1.3*

52.8 ± 3.2*

15.2 ± 0.9

28.5 ± 3.4*

30 days

3

34.4 ± 2.4

73.9 ± 5.0

14.3 ± 1.9

16.3 ± 2.4

5 months

3

43.2 ± 2.7

66.8

± 4.4

21.5 ± 1.9

3.5 ± 0.9

controls

6

51.1 ± 7.5

36.5 ± 3.0

54.8 ± 1.3

8.0

3 days

3

64.8 ± 1.0

39.9 ± 0.4

43.3 ± 1.3*

11.6 ± 0.3

5 days

3

42.4 ± 1.8*

41.5 ± 3.1

47.4 ± 1.7*

13.7 ± 1.4

days

3

37.6 ± 0.8*

37.7 ± 1.8

51.5 ± 2.5

15 days

3

72.0 ±

6.6

51.1 ± 4.3*

43.1 ± 3.8*

12.7 ± 3.3

30 days

3

47.4 ± 5.4

56.9 ± 3.5*

32.5 ± 3.0*

9.6 ± 3.2

10

C57BL/6 mice
(susceptible)

10

a
b
c

%75+c
2.2

5 months
3
54.8 ± 2.6
34.8 ± 2.9
45.0 ± 5.3
Postinoculation interval with Mycobacterium paratuberculosis.
Percentage of the total lymphocytes expressing CD3 ± standard error,
Expressed as a percentage of total CD3+ cells ± standard error.

10.8

±

±

2.0

0.6

7.0 ± 0.5

9.0 + 3.6

Indicates a significant difference (P<0.05) from the uninfected controls.

Table C.4. Summary of the kinetics of the T cell response of the intestinal
intraepithelial lymphocytes of C57BL/6 and C3H/He mice infected with M. paratuberculosis.
C3H/He mice
(resistant)

PI int.®

n

%CD3+b

controls

4

83.1 ± 2.3

3 days

3

5 days

%CD 8 +c

%7«+c

7.9 ± 0.6

92.7 ± 1.0

73.7 ± 2.6

74.4 ± 7.9

10.7 ± 4.8

97.6 ± 1.5

56.3 ± 11.1

3

80.3 ± 1.1

8.4 ± 1.0

95.3 ± 2.2

60.0 ±10.7*

days

3

85.5 ± 3.6

5.8 ± 2.4

88.1 ± 4.1

80.7 ± 5.8

15 days

3

75.1 ± 5.1

24.0 ± 9.7*

87.9 ± 2.6

81.1 ±

30 days

3

70.6 ± 2.7

22.2 ± 6.9*

72.2 ± 13.3*

73.6 ± 7.0

5 months

3

89.6 ± 0.3

29.7 ± 7.1

89.2 ± 1.8

18.3 ± 7.4

controls

3

82.0 ± 2.9

8.7 ± 1.8

85.8 ± 2.2

81.2 ± 3.5

3 days

3

89.6 ± 0.3

5.8 ± 0.1

87.4 ± 0.3

84.2 ± 1.3

5 days

3

85.8 ± 1.1

6.6

±

1.1

90.5 ± 1.1

83.6 ± 1.2

days

3

89.7 ± 3.2

4.2 ± 1.1

93.2 ± 0.6

79.5 ± 12.0

15 days

3

80.9 ± 1.3

9.5 ± 2.2

94.0 ± 1.9

89.7 ± 3.0

30 days

3

84.7 ± 3.7

7.8 ± 1.9

87.6 ± 3.5

88.2

10

C57BL/6 mice
(susceptible)

10

a
b
c

%CD4+c

5 months
3
93.7 ± 1.3
4.0 ± 1.5
89.4 ± 1.5
Postinoculation interval with Mvcobactermm paratuberculosis.
Percentage of the total lymphocytes expressing CD3 ± standard error,
Expressed as a percentage of total CD3+ cells ± standard error.

±

2.1

1.2

67.6 ± 3.4

Indicates a significant difference (P<0.05) from the uninfected controls.

Table C.5. Summary of the kinetics of the T cell response in the lamina propria of
C57BL/6 and C3H/He mice to infection with Mycobacterium paratuberculosis.
C3H/He mice
(resistant)

PI int."

n

%CD3+b

%CD4+c

%CD 8 +c

%y5+c

controls

3

83.1 ± 2.3

64.8 ± 4.9

24.1 ± 1.1

40.7 ± 10.5

3 days

3

54.3 ± 2.3*

28.6 ±

64.6 ± 5.8*

39.1 ± 3.2

5 days

3

48.0 ± 1.6*

45.6 ± 2.3

47.2 ± 3.0*

37.1 ± 2.5

days

3

62.2 ± 4.7*

57.7 ± 4.6

42.0 ± 7.2

16.1 ± 3.0*

15 days

3

45.2 ± 2.8

53.4 ± 0.8

41.0 ± 1.1

41.5 ± 2.4

30 days

3

36.2 i 2.3

72.4 ± 7.1

19.5 ± 2.0

30.3 ± 3.1*

5 months

3

53.5 ± 7.8

58.1 ± 9.6

40.5 ± 7.4

5.1 ± 0.9

controls

6

40.5 ± 7.4

48.4 ± 2.4

32.5 ± 4.6

40.0 ± 4.6

3 days

3

47.0 ± 6.3

31.1 ± 5.0*

54.5 ± 6.0*

61.9 ± 5.1*

5 days

3

43.7 ± 7.0

36.4 ± 10.7*

47.7 ± 8.0*

39.5 ± 4.8

days

3

48.3 ± 7.5*

37.3 ± 4.3

36.9 ± 4.6

46.5 ± 10.3

15 days

3

62.8 ±

35.8 ±

64.5 ± 15.7*

62.9 ± 9.9*

30 days

3

48.8 ± 2.2

18.2 ± 3.2

26.4 ± 3.3

10

C57BL/6 mice
(susceptible)

10

a
b
c

2

.8 *

2

.0 *

8.6

65.9 ± 2.7*

5 months
3
51.3 ± 13.8
29.3 ± 4.2
47.5 ± 7.4
Postinoculation interval with Mycobacterium paratuberculosis.
Percentage of the total lymphocytes expressing CD3 ± standard error,
Expressed as a percentage of total CD3+ cells standard error.

52.0 ± 13.7

Indicates a significant difference (P<0.05) from the uninfected controls.

Table C. 6 . Kinetics of the T cell response in the Peyer's Patches in response to
intraperitoneal infection with Mycobacterium paratuberculosis. Each value represents
pooled sample of at least 3 mice.

C3H/He mice
(resistant)

C57BL/6 mice
(susceptible)

a
b
c

P.I. int .8

%CD3+b

%CD4+c

%CD 8 +*

%7«+c

0

46.2

59.7

27.3

18.8

3

44.2

79.4

12.7

8.0

5

39.0

83.8

20.8

10.0

10

70. 3

73.1

27.9

13.2

15

60.5

45.5

62.8

42.3

30

53.3

66.2

24.8

13.9

5m

61.5

67.1

22.5

3.6

0

44.9

44.9

40.4

39.3

3

63 .9

41.9

40.5

31.8

5

48.5

53 .4

43.9

39.0

10

76.0

24.1

67.1

68.0

15

—

—

—

—

30

70.6

42.6

52.7

29.3

5m

66.7

44.2

15.3

8.4

Postinoculation interval with Mycobacterium paratuberculosis.
Percentage of the total lymphocytes expressing CD3.
Expressed as a percentage of the total CD3+ cell population.

Table C.7. Summary of the kinetics of the T cell response in the mesenteric lymph nodes
of C57BL/6 and C3H/He mice to infected with Mvcobacterium paratuberculosis.
C3H/He mice
(resistant)

C57BL/6 mice
(susceptible)

a
b
c

PI int.*

n

%CD3+b

%CD4+c

%CD8+°

%yS+c

controls

3

93.1 ± 2.0

73.2 ± 0.9

26.0 ± 0.3

1.4 ± 0.1

3 days

3

96.8 ± 1.0

71.0 ± 0.6

29.0 ± 1.2

0.8 ± 0.3

5 days

3

79.2 ± 0.7

70.4 ± 3.1

23.9 ± 1.2

1.1 ± 0.2

10 days

3

88.2 ± 0.8

69.2 ± 1.3

26.5 ± 0.8

2.1 ± 0.2

15 days

3

96.4 ± 1.2

68.0 ± 0.8

28.9 ± 1.5

2.1 ± 0.1

30 days

3

92.1 ± 1.6

69.7 ± 1.2

28.7 ± 1.7

2.3 ± 0.2

controls

9

82.7 ± 2.3

42.3 ± 3.1

49.1 ± 1.7

5.0 ± 0.6

3 days

3

83.6 ± 4.6

34.5 ± 3.6*

61.6 ± 3.5*

9.4 ± 0.3*

5 days

3

60.5 ± 7.4

48.0 ± 2.7

44.4 ± 1.7

7.5 ± 0.8*

10 days

6

70.2 ± 5.2

38.2 ± 2.7

51.1 ± 2.4

7.3 ± 2.4

15 days

3

69.7 ± 3.4

49.1 ± 7.2*

37.5 ± 2.2*

9.0 ± 0.3*

30 days
3
82.4 ± 4.1
46.2 ± 2.9
47.8 ± 2.0
8.6 ± 0.5*
Post inoculation interval with Mvcobacterium paratuberculosis.
Percentage of the total lymphocytes expressing CD3 ± standard error,
Expressed as a percentage of total CD3+ cells ± standard error.
Indicates a significant difference (P<0.05) from the uninfected controls.

APPENDIX D.

TABLES OF CD25 AND CD44 EXPRESSION
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Cellular expression of activation markers CD44 and CD25 in the peritoneal
exudate of young C57BL/6 and C3H/He mice infected with Mycobacterium paratuberculosis.

Table D.l.

C3H/He mice
(resistant)

C57BL/6 mice
(susceptible)

a
b
c

PI int.*

n

Total CD44+b

DP CD4/CD44+'

Total CD25+b

DPCD4/CD25+0

controls

6

91.2 ± 2.5

53.1 ± 6.0

2.5 ± 1.3

8.8 ± 1.2

3 days

3

72.0 + 6.3*

63.1 ± 10.7

3.6 ± 2.1

4.5 ± 1.7*

5 days

3

47.0 ± 2.4

23.6 ± 0.9*

1.8 ± 0.1*

2.6 ± 0.2*

10 days

3

83.0 ± 6.0

65.7 ± 13.8

4.2 ± 1.2*

24.6 ± 21.5

15 days

3

90.1 ± 2.4

54.4 ± 2.5

9.5 ± 3.9*

11.7 ± 4.0

30 days

3

70.0 ± 12.0*

44.7 ± 12.0

2.6 ± 0.6

3.0 + 0.9*

5 months

3

98.4 ± 0.1*

92.3 ± 3.0*

0.6 ± 0.03

30.3 ± 4.1*

controls

6

97.2 ± 1.7

62.9 + 10.4

8.2 ± 1.0

32.0 ± 9.0

3 days

3

90.4 ± 0.9*

53.5 ± 7.1

5.1 ± 0.5*

4.1 ± 2.3*

5 days

3

94.8 ± 1.3

52.9 ± 21.1

4.2 ± 0.9*

13.8 ± 5.7

10 days

3

91.6 ± 1.1*

80.0 ± 9.9

3.6 ± 0.6*

6.1 ± 1.6*

15 days

3

87.6 ± 9.2

77.5 ± 11.8

4.4 ± 0.9*

6.2 ± 0.5*

30 days

3

89.6 + 1.7*

72.3 ± 6.6

2.5 ± 0.2*

4.2 ± 1.5*

5 months

3

99.0 ± 0.2

82.5 ± 9.8

4.5 ± 1.2*

14.0 ± 6.1

Postinoculation interval with Mycobacterium paratuberculosis.
Percentage of the total lymphocytes expressing CD44 or CD25 ± standard error,
Percentage of the total CD4+ cells co-expressing CD44 or CD25 ± standard error.
Indicates that the value differs from the uninfected control mean
with a P value of less than 0.1.

Table D.2. Summary of the cellular expression of activation markers CD44 and CD25 in the
peritoneal exudate of aged (retired breeders) C57BL/6 and C3H/He mice infected with
Mycobacterium paratuberculosis.

C3H/He mice
(resistant)

C57BL/6 mice
(susceptible)

a
b
*

PI int.*

n

Total CD44+b

Total CD25+b

controls

3

87.7 ± 3.6

1.3 ± 0.7

5 days

3

29.6 ± 4.6*

2.2 ±0.1*

10 days

3

44.7 ± 11.9*

2.5 ± 0.6

15 days

3

56.2 ± 3.3*

3.4 + 0.6*

30 days

3

42.7 ± 4.9*

5.6 ± 0.4*

controls

6

85.7 ± 9.2

6.7 ± 0.6

5 days

3

70.5 ± 8.2

2.5 ± 1.0*

10 days

3

79.3 ± 1.6

2.4 ± 0.1*

15 days

3

87.2 ± 0.3

3.4 ± 0.4*

30 days

3

77.4 ± 9.2

3.8 ± 1.3

Postinoculation interval with Mycobacterium paratuberculosis.
Mean percentage of the total lymphocytes expressing CD44 or CD25 ± standard error.
Indicates that the value differs from the uninfected control mean
with a P value of less than 0.05.

Table D.3. Cellular expression of activation markers CD44 and CD25 in the spleens of
C57BL/6 and C3H/He mice infected with Mvcobacter ium paratuberculosis.
C3H/He mice
(resistant)

C57BL/6 mice
(susceptible)

a
b
c

PI int.“

n

Total CD44+b

DPCD4/CD44+c

Total CD25+b

DPCD4/CD25+c

controls

7

70.5 ± 3.3

26.1 ± 2.5

3.3 ± 0.7

6.1 ± 0.6

3 days

3

63.5 ± 2.8

27.7 ± 2.7

4.0 ± 0.1

9.6 ± 1.3*

5 days

3

60.8 ± 2.2*

30.8 ± 1.9

3.4 ± 0.2

8.4 ± 0.5*

10 days

3

53.2 ± 5.1

20.7 ± 1.3

2.5 + 0.3

5.3 ± 0.2

15 days

3

78.1 ± 3.4

37.6 ± 8.9

3.4 ± 0.7

7.7 ± 1.7

30 days

3

58.7 ± 4.4*

37.0 ± 3.2*

2.5 ± 0.3

7.9 ±1.8

5 months

3

71.0 ± 2.5

37.1 ± 0.1

2.3 ± 0.6

4.7 ± 1.2

controls

6

73.5 ± 1.0

35.9 + 1.0

2.1 ± 0.2

5.5 + 0.3

3 days

3

75.9 + 1.4

43.7 ± 1.0*

3.8 ± 0.3*

8.1 ± 0.6*

5 days

3

77.2 ± 2.2*

42.5 ± 1.0*

2.0 ± 0.2

6.8 ± 0.8*

10 days

3

74.7 ± 2.1

45.6 ± 3.5*

3.0 ± 0.3*

6.9 ± 0.8*

15 days

3

80.5 ± 5.7*

55.3 ± 7.4*

3.7 ± 0.3*

7.8 ± 1.5*

30 days

3

74.1 ± 2.0

73.5 ± 1.0

1.5 ± 0.2

4.5 ± 0.7

5 months

3

90.7 ± 1.3*

79.3 ± 8.6*

1.1 ± 0.3*

4.8 ± 2.6

Postinoculation interval with Mvcobacterium paratuberculosis.
Mean percentage of the total lymphocytes expressing CD44 or CD25 ±
Mean percentage of the total CD4+ cells co-expressing CD44 or CD25
positive) ± standard error.
Indicates that the value differs from the uninfected control mean
with a P value of less than 0.1.

standard error,
(double

Table D.4. Cellular expression of activation markers CD44 and CD25 amongst
intraepithelial lymphocytes (IEL) of C57BL/6 and C3H/He mice infected with Mycobacterium
paratuberculosis.
C3H/He mice
(resistant)

C57BL/6 mice
(susceptible)

a
b
c

PI int.'*

n

Total CD44+b

DPCD4/CD44+c

Total CD25+b

DPCD4/CD25+'

controls

3

29.3 ± 2.7

63.2 ± 12.9

3.7 ± 1.4

10.8 ± 4.5

3 days

3

39.0 ± 5.3

73.4 ± 14.8

3.8 ± 0.9

9.7 ± 3.6

5 days

3

29.8 ± 1.9*

73.6 ± 5.3

1.9 + 0.6

7.0 ± 2.7

10 days

3

19.6 ± 7.3

78.5 ± 8.8

2.0 ± 0.5

23.2 ± 10.5

15 days

3

49.6 ± 4.8*

78.0 ± 9.0

3.9 ± 0.6

7.0 ± 2.6

30 days

3

64.3 ± 2.1*

80.5 ± 2.9

5.9 ± 1.0

22.1 ± 4.6

5 months

3

64.0 ± 5.0*

96.7 ± 1.6*

3.6 ± 0.5

1.7 ± 0.5

controls

6

28.4 + 1.5

47.1 + 1.5

4.6 ± 1.0

5.2 ± 1.3

3 days

3

28.7 ± 2.3

65.3 ± 6.4*

2.3 ± 0.4*

11.5 ± 2.8

5 days

3

23.2 ± 1.0*

69.6 ± 7.5*

1.5 ± 0.2

6.8 ± 2.2

10 days

3

32.0 ± 2.7

82.0 ± 11.2*

2.1 ± 1.0

7.6 ± 2.8

15 days

3

42.0 ± 2.8*

67.5 ± 6.7*

3.1 ± 0.9

12.0 ± 1.4*

30 days

3

31.0 ± 2.5

83.1 ± 4.3*

2.1 ± 0.4

9.6 ± 2.0

5 months

3

32.2 ± 8.0

90.7 ± 2.9*

0.9 ± 0.5*

6.3 i 1.4

Post inoculation interval with Mycobacterium paratuberculosis.
Mean percentage of the total lymphocytes expressing CD44 or CD25 ± standard error,
Mean percentage of the total CD4+ cells co-expressing CD44 or CD25 (double
positive) ± standard error.
Indicates that the value differs from the uninfected control mean
with a P value of less than 0.1.

Table D.5. Cellular expression of activation markers CD44 and CD25 of lamina propria
lymphocytes (LPL) of C57BL/6 and C3H/He mice infected with Mycobacterium paratuberculosis.
C3H/He mice
(resistant)

C57BL/6 mice
(susceptible)

a
b
c
*
f

PI int.*

n

Total CD44+b

DPCD4/CD44+c

Total CD25+b

DPCD4/CD25+c

controls

3

85.3 ± 2.9

61.9 ± 14.6

5.9 ± 0.7

5.9 ± 0.8

3 days

3

70.5 ± 9.5

70.5 ± 9.5

2.2 ± 0.2*

3.1 ± 0.7*

5 days

3

77.9 + 3.1

77.9 ± 3.1

4.7 ± 0.5

5.8 + 1.1

10 days

3

49.9 ± 21.7

49.9 ±

4.1 ± 1.3

3.3 ± 0.5*

15 days

3

97.2 ± 2.7*

97.2 + 2.7*

6.7 ± 3.9

3.2 ± 0.8*

30 days

3

88.9 ± 3.7

88.9 ± 3.7

5.3 + 2.3

6.9 ± 2.1

5 months

3

92.7 ± 3.6

92.7 ± 3.6

31.4 ± 28.5

1.8 + 0.7*

controls

6

67.6 ± 8.5

63.0 ± 9.7

7.5 ± 3.5

11.9 ± 5.7

3 days

3

70.9 ± 6.6

67.6 ± 2.0

9.6 ± 1.9

15.3 ± 3.9

5 days

3

62.5 ± 3.6

71.3 ± 3.2

3.6 ± 0.4

4.9 ± 0.2

10 days

3t

45.3 ± 5.9*

64.8f

3.8 + 1.8

15 days

3

72.0 ± 6.1

91.1 ± 3.0*

4.6 ± 1.3

9.6 ± 4.6

30 days

3

88.7 ± 0.9

91.4 ± 1.4*

3.9 ± 0.7

5.2 ± 0.7

5 months

3

62.0 ± 20.5

50.8 ± 19.6

14.2 ± 1.7

45.3 ± 21.9

21.7

Postmoculation interval with Mvcobacter ium paratuberculosis.
Mean percentage of the total lymphocytes expressing CD44 or CD25 ±
Mean percentage of the total CD4+ cells co-expressing CD44 or CD25
positive) ± standard error.
Indicates that the value differs from the uninfected control mean
with a P value of less than 0.1.
Samples were pooled and therefore only the mean was reported.

ND

standard error,
(double

Table D.6. Summary of the cellular expression of activation markers CD44 and CD25 in the
mesenteric lymph nodes of C57BL/6 and C3H/He mice infected with Mycobacterium
paratuberculosis.
C3H/He mice
(resistant)

PI int.®

n

Total CD44+b

DPCD4/CD44+c

Total CD25+b

DPCD4/CD25+c

controls

2

12.9 ± 3.2

7.6 ± 1.0

2.2 ± 0.05

2.8 ± 0.0

3 days

3

14.0 ± 4.2

11.1 ± 3.1

2.4 ± 0.4

2.8 ±0.3

5 days

3

33.8 ± 7.4*

16.9 ± 3.8

2.4 ± 0.4

3.5 ± 0.6

10 days

3t

20.7t

10. Of

3. Of

4.4t

15 days

3t

19. 3t

4.3f

3.It

15.4t

30 days

3

39.3 ± 0.7*

36.5 + 0.5*

3.3 ± 0.6

3.8 ± 0.0

5 months

3

42.3 ± 0.4*

33.1 ± 2.4*

4.1 ± 0.2*

0.3 ± 0.1

controls

9

52.2 ± 1.9

34.2 ± 3.5

11.1 ± 4.6

7.1 ± 2.9

3 days

3

51.5 ± 1.5

40.2 ± 1.9

2.4 ± 0.3

5.1 ± 0.2

5 days

3

62.1 ± 2.5*

28.0 ± 2.2

2.7 + 0.7

5.0 ± 0.9

10 days

3

71.5 ± 3.5*

67.9 ± 3.3*

6.0 ± 1.0

3.1 ± 0.1

15 days

3t

72.3f

52. 6t

6.7t

10.9t

30 days

3

55.6 ± 4.6

45.5 ± 2.8*

2.1 ± 0.3

4.5 ± 0.6

5 months
1
1"K "
■.

3

C57BL/6 mice
(susceptible)

a
b
c
*
t

.

ND

ND

ND

Postinoculation interval with Mycobacterium paratuberculosis.
Mean percentage of the total lymphocytes expressing CD44 or CD25 ±
Mean percentage of the total CD4+ cells co-expressing CD44 or CD25
positive) ± standard error.
Indicates that the value differs from the uninfected control mean
with a P value of less than 0.1.
Samples were pooled and therefore only the mean is reported.

ND

standard error,
(double

Table D.7. Summary of the cellular expression of activation markers CD44 and CD25 in the
Peyer's patches of C57BL/6 and C3H/He mice infected with Mycobacterium paratuberculosis.
Samples from each group were pooled.______________________
________
C3H/He mice
(resistant)

C57BL/6 mice
(susceptible)

a
b

P.I. Int.*

%CD44

%DP
CD4/44b

%CD25

%DP
CD4/25b

Control

47.6

18.8

4.7

5.4

3 days

69.2

53.3

2.2

2.8

5 days

67.8

46.2

2.9

3.4

10 days

58.4

42.0

3.0

3.3

15 days

66.0

60.1

4.1

6.2

30 days

75.1

55.5

5.1

9.3

5 months

71.3

48.5

5.9

4.4

Control

71.0

56.0

5.0

5.4

3 days

68.4

63.4

2.5

2.2

5 days

64.2

54.8

2.3

3.1

10 days

54.6

67.8

1.9

3.8

15 days

ND

ND

ND

ND

30 days

73.0

72.1

3.2

4.7

5 months
88.4
61.3
8.6
3.3
Postmoculation interval with Mvcobactermm paratuberculosis.
Percent double positive cells co-expressing CD4 and either CD44 or CD25.
oo
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